<SEC-DOCUMENT>0001104659-25-067813.txt : 20250715
<SEC-HEADER>0001104659-25-067813.hdr.sgml : 20250715
<ACCEPTANCE-DATETIME>20250714180136
ACCESSION NUMBER:		0001104659-25-067813
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20250715
DATE AS OF CHANGE:		20250714

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Datavault AI Inc.
		CENTRAL INDEX KEY:			0001682149
		STANDARD INDUSTRIAL CLASSIFICATION:	SEMICONDUCTORS & RELATED DEVICES [3674]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				301135279
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-288596
		FILM NUMBER:		251122618

	BUSINESS ADDRESS:	
		STREET 1:		15268 NW GREENBRIER PKWY
		CITY:			BEAVERTON
		STATE:			OR
		ZIP:			97006
		BUSINESS PHONE:		408-627-4716

	MAIL ADDRESS:	
		STREET 1:		15268 NW GREENBRIER PKWY
		CITY:			BEAVERTON
		STATE:			OR
		ZIP:			97006

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WISA TECHNOLOGIES, INC.
		DATE OF NAME CHANGE:	20220311

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Summit Wireless Technologies, Inc.
		DATE OF NAME CHANGE:	20180914

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Summit Semiconductor Inc.
		DATE OF NAME CHANGE:	20180501
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>tm2520064d5_424b3.htm
<DESCRIPTION>424B3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Prospectus </FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">Filed Pursuant to Rule 424(b)(3)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">Registration No. 333-288596</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2520064d4_s3img001.jpg" ALT=""></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Datavault
AI Inc.</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>22,728,368
Shares of Common Stock</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issuable
Upon Exercise of Certain Common Stock Purchase Warrants</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus relates to the offer and resale of (a)&#160;up to an aggregate of 2,906,554 shares (the &#8220;September&#160;2024 Warrant
Shares&#8221;) of common stock, par value $0.0001 per share (&#8220;Common Stock&#8221;), of Datavault AI Inc., a Delaware corporation
(the &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221; or &#8220;our&#8221;), issuable upon exercise of certain common stock
purchase warrants (the &#8220;September&#160;2024 Warrants&#8221;) issued on September&#160;10, 2024 pursuant to certain exchange agreements
(the &#8220;Exchange Agreements&#8221;) between the Company and the holders of the September&#160;2024 Warrants, (b)&#160;up to an aggregate
of 475,713 shares of Common Stock (the &#8220;Placement Agent Warrant Shares&#8221;) issuable upon exercise of certain common stock purchase
warrants (the &#8220;Placement Agent Warrants&#8221;) issued to an affiliate of Maxim Group LLC (the &#8220;Placement Agent&#8221;) pursuant
to that certain placement agency agreement (the &#8220;February&#160;2025 Placement Agency Agreement&#8221;) between the Company and
the Placement Agent entered into on February&#160;13, 2025, and (c)&#160;up to an aggregate of 19,346,101 shares (the &#8220;2025 Investor
Warrant Shares&#8221;) of Common Stock issuable upon exercise of certain common stock purchase warrants (the &#8220;2025 Investor Warrants&#8221;)
issued pursuant to that certain securities purchase agreement (the &#8220;Purchase Agreement&#8221;) between the Company and the investors
signatories to the Purchase Agreement (the &#8220;April&#160;2025 Purchasers&#8221;) entered into on March&#160;31, 2025. The September&#160;2024
Warrant Shares, the Placement Agent Warrant Shares and the 2025 Investor Warrant Shares are collectively referred to as the &#8220;Warrant
Shares,&#8221; and the holders of the Warrant Shares are collectively referred to as the &#8220;Selling Stockholders.&#8221;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
additional information regarding the issuance of the September&#160;2024 Warrants, see &#8220;The September&#160;2024 Transaction&#8221;
on page&#160;22. For additional information regarding the issuance of the Placement Agent Warrants, see &#8220;The February&#160;2025
Transaction&#8221; on page&#160;22. For additional information regarding the issuance of the 2025 Investor Warrants, see &#8220;The April&#160;2025
Transaction&#8221; on page&#160;23.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus also covers any additional shares of Common Stock that may become issuable upon any adjustment pursuant to the terms of the
Warrants issued to the Selling Stockholders by reason of stock splits, stock dividends, and other events described therein.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares will be resold from time to time by the Selling Stockholders listed in the section titled &#8220;Selling Stockholders&#8221;
beginning on page&#160;25.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders, or their respective transferees, pledgees, donees or other successors-in-interest, will sell the Warrant Shares
through public or private transactions at prevailing market prices, at prices related to prevailing market prices or at privately negotiated
prices. The Selling Stockholders may sell any, all or none of the securities offered by this prospectus, and we do not know when or in
what amount the Selling Stockholders may sell their Shares hereunder following the effective date of this registration statement. We
provide more information about how a Selling Stockholder may sell its Shares in the section titled &#8220;Plan of Distribution&#8221;
on page&#160;36.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are registering the Warrant Shares on behalf of the Selling Stockholders, to be offered and sold by them from time to time. While we
will not receive any proceeds from the sale of the Warrant Shares by the Selling Stockholders in the offering described in this prospectus,
we may receive $2.21 per share for the September&#160;2024 Warrants, $1.425 per share for the Placement Agent Warrants and $0.8615 per
share for the 2025 Investor Warrants (each, subject to adjustment as further described below) upon their cash exercise. If the Warrants
are exercised in full at their respective current exercise price per share, we will receive aggregate gross proceeds of approximately
$23,768,041. The exercise price for the 2025 Investor Warrants may be adjusted downwards pursuant to the terms of anti-dilution features
contained therein under certain circumstances, and if any of the 2025 Investor Warrants are exercised at such lower price, we will receive
less aggregate gross proceeds. If the Warrants are exercised pursuant to the cashless exercise provisions contained therein, we will
also receive less aggregate gross proceeds. We cannot predict when and in what amounts or if the Warrants will be exercised, and it is
possible that the Warrants may expire and never be exercised, in which case we would not receive any cash proceeds. We have agreed to
bear all of the expenses incurred in connection with the registration of the Warrant Shares. The Selling Stockholders will pay or assume
discounts, commissions, fees of underwriters, selling brokers or dealer managers and similar expenses, if any, incurred for the sale
of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is currently listed on the Nasdaq Capital Market (&#8220;Nasdaq&#8221;) under the symbol &#8220;DVLT&#8221;.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>This
offering will terminate on the earlier of (i)&#160;the date when all of the securities registered hereunder have been sold pursuant to
this prospectus or Rule&#160;144 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and (ii)&#160;the date
on which all of such securities may be sold pursuant to Rule&#160;144 without volume or manner-of-sale restrictions, unless we terminate
it earlier.</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investing
in our Common Stock involves risks. You should carefully review the risks described under the heading &#8220;Risk Factors&#8221; beginning
on page&#160;6 and in the documents which are incorporated by reference herein before you invest in our Common Stock.</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined
if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus is July 11, 2025.</P>
<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Page</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><A HREF="#a_001">ABOUT THIS PROSPECTUS</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><A HREF="#a_001">2</A></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><A HREF="#a_002">SPECIAL NOTE REGARDING FORWARD-LOOKING
    STATEMENTS</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_002">2</A></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><A HREF="#a_003">INDUSTRY AND MARKET DATA</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_003">3</A></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><A HREF="#a_004">PROSPECTUS SUMMARY</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_004">3</A></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><A HREF="#a_005">ABOUT THIS OFFERING</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_005">5</A></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><A HREF="#a_006">RISK FACTORS</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_006">6</A></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><A HREF="#km_002">THE SEPTEMBER 2024 TRANSACTION</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#km_002">22</A></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><A HREF="#km_003">THE FEBRUARY 2025 TRANSACTION</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#km_003">22</A></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><A HREF="#km_004">THE APRIL 2025 TRANSACTION</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#km_004">23</A></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><A HREF="#km_005">SELLING STOCKHOLDERS</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#km_005">25</A></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><A HREF="#km_006">USE OF PROCEEDS</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#km_006">34</A></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><A HREF="#km_007">DESCRIPTION OF SECURITIES THAT THE SELLING
    STOCKHOLDERS ARE OFFERING</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#km_007">35</A></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><A HREF="#km_008">PLAN OF DISTRIBUTION</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#km_008">36</A></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><A HREF="#km_009">DISCLOSURE OF COMMISSION POSITION ON
    INDEMNIFICATION FOR SECURITIES ACT LIABILITY</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#km_009">38</A></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><A HREF="#km_010">LEGAL MATTERS</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#km_010">38</A></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><A HREF="#km_011">EXPERTS</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#km_011">38</A></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><A HREF="#km_012">WHERE YOU CAN FIND MORE INFORMATION</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#km_012">38</A></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><A HREF="#km_013">INCORPORATION OF CERTAIN DOCUMENTS BY
    REFERENCE</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#km_013">39</A></TD></TR>
  </TABLE>


<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_001"></A>ABOUT
THIS PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus describes the general manner in which the Selling Stockholders may offer from time to time up to 22,728,368 shares of Common
Stock. You should rely only on the information contained in this prospectus and the related exhibits, any prospectus supplement or amendment
thereto and the documents incorporated by reference, or to which we have referred you, before making your investment decision. Neither
we nor the Selling Stockholders have authorized anyone to provide you with different information. If anyone provides you with different
or inconsistent information, you should not rely on it. This prospectus, any prospectus supplement or amendments thereto do not constitute
an offer to sell, or a solicitation of an offer to purchase, the shares of Common Stock offered by this prospectus, any prospectus supplement
or amendments thereto in any jurisdiction to or from any person to whom or from whom it is unlawful to make such offer or solicitation
of an offer in such jurisdiction. You should not assume that the information contained in this prospectus, any prospectus supplement
or amendments thereto, as well as information we have previously filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;),
is accurate as of any date other than the date on the front cover of the applicable document.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
necessary, the specific manner in which the shares of Common Stock may be offered and sold will be described in a supplement to this
prospectus, which supplement may also add, update or change any of the information contained in this prospectus. To the extent there
is a conflict between the information contained in this prospectus and any prospectus supplement, you should rely on the information
in such prospectus supplement, provided that if any statement in one of these documents is inconsistent with a statement in another document
having a later date &#8212; for example, a document incorporated by reference in this prospectus or any prospectus supplement &#8212;
the statement in the document having the later date modifies or supersedes the earlier statement.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the delivery of this prospectus nor any distribution of shares of Common Stock pursuant to this prospectus shall, under any circumstances,
create any implication that there has been no change in the information set forth or incorporated by reference into this prospectus or
in our affairs since the date of this prospectus. Our business, financial condition, results of operations and prospects may have changed
since such date.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
used herein, unless the context requires otherwise, references to &#8220;DVLT&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;our&#8221;
or &#8220;us&#8221; refer to Datavault AI Inc., a Delaware corporation, and its subsidiaries on a consolidated basis.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_002"></A>SPECIAL
NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus, any amendment and the information incorporated by reference into this prospectus, including the sections entitled &#8220;Risk
Factors&#8221;, contain &#8220;forward-looking statements&#8221; within the meaning of Section&#160;21(E)&#160;of the Securities Exchange
Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and Section&#160;27A of the Securities Act. These forward-looking statements
include, without limitation: statements regarding new products or services; statements concerning litigation or other matters; statements
concerning projections, predictions, expectations, estimates or forecasts for our business, financial and operating results and future
economic performance; statements of our management&#8217;s goals and objectives; statements concerning our competitive environment, availability
of resources and regulation; trends affecting our financial condition, results of operations or future prospects; our financing plans
or growth strategies; and other similar expressions concerning matters that are not historical facts. Words such as &#8220;may&#8221;,
 &#8220;will&#8221;, &#8220;should&#8221;, &#8220;could&#8221;, &#8220;would&#8221;, &#8220;predicts&#8221;, &#8220;potential&#8221;,
 &#8220;continue&#8221;, &#8220;expects&#8221;, &#8220;anticipates&#8221;, &#8220;future&#8221;, &#8220;intends&#8221;, &#8220;plans&#8221;,
 &#8220;believes&#8221; and &#8220;estimates,&#8221; and variations of such terms or similar expressions, are intended to identify such
forward-looking statements.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the
times at, or by which, that performance or those results will be achieved. Forward-looking statements are based on information available
at the time they are made and/or our management&#8217;s good faith belief as of that time with respect to future events. Our actual results
may differ materially from those expressed in, or implied by, the forward-looking statements due to a number of factors including, but
not limited to, those set forth under the heading &#8220;Risk Factors&#8221; in this prospectus, as well as other risks discussed in
documents that we file with the SEC.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements speak only as of the date they are made. You should not put undue reliance on any forward-looking statements. We assume no
obligation to update forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting
forward-looking information, except to the extent required by applicable securities laws. If we do update one or more forward-looking
statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.
You should review our subsequent reports filed with the SEC described in the sections of this prospectus and the accompanying prospectus
entitled &#8220;Where You Can Find More Information&#8221; and &#8220;Incorporation of Certain Documents by Reference,&#8221; all of
which are accessible on the SEC&#8217;s website at <FONT STYLE="text-decoration: underline solid"><I>www.sec.gov</I></FONT>.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_003"></A>INDUSTRY
AND MARKET DATA</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated, information contained in this prospectus concerning our industry and the market in which we operate, including our
market position, market opportunity and market size, is based on information from various sources, on assumptions that we have made based
on such data and other similar sources and on our knowledge of the markets for our products. These data sources involve a number of assumptions
and limitations, and you are cautioned not to give undue weight to such estimates.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not independently verified any third-party information. While we believe the market position, market opportunity and market size
information included in this prospectus is generally reliable, such information may be imprecise. In addition, projections, assumptions
and estimates of our future performance and the future performance of the industry in which we operate is necessarily subject to a high
degree of uncertainty and risk due to a variety of factors, including those described in the section titled &#8220;Risk Factors&#8221;
and elsewhere in this prospectus and in any documents that we incorporate by reference into this prospectus and the registration statement
of which this prospectus forms a part. These and other factors could cause results to differ materially from those expressed in the estimates
made by the independent parties and by us.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_004"></A>PROSPECTUS
SUMMARY</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
summary highlights selected information contained elsewhere in this prospectus or incorporated by reference into this prospectus. This
summary does not contain all of the information that you should consider before investing in our Common Stock. You should carefully read
this entire prospectus, and our other filings with the SEC, including the following sections, which are either included herein and/or
incorporated by reference herein, &#8220;Risk Factors&#8221;, &#8220;Special Note Regarding Forward-Looking Statements&#8221;, &#8220;Management&#8217;s
Discussion and Analysis of Financial Condition and Results of Operations&#8221; and the consolidated financial statements incorporated
by reference herein, before making a decision about whether to invest in our securities.</I></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company
Overview</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a pioneering technology licensing company that owns a portfolio of patented, secure platforms designed to redefine how data is managed,
valued, and monetized in the modern era. Leveraging our proprietary HPC capabilities and advanced software, we aim to empower customers
worldwide with revolutionary data solutions. At the heart of our offerings are our artificial intelligence (AI)-driven agents&#8212;branded
as Data Vault&#174;, DataValue&#174;, DataScore&#174;, and Data Vault Bank&#174;. These tools harness generative AI to deliver enterprise-grade
data management solutions tailored for the HPC landscape and the Web 3.0 paradigm. Our technology ensures data ownership immutability,
experiential data observability, precise data asset valuation, and secure monetization&#8212;which we believe will unlock unprecedented
opportunities for businesses in an increasingly data-driven world on which our executive leadership, with our engineering and software
development teams, can capitalize. Our legacy business has been well positioned to deliver best-in-class immersive wireless sound technology
for intelligent devices and next generation home entertainment systems, including modules which wirelessly transmit and receive audio
directly to speakers. We operate through two synergistic platforms (Data Science and Acoustic Science) to optimize our revenue generation.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risk
Factor Summary</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are a number of risks related to our business and our securities. You should carefully consider all the information presented in the
section entitled &#8220;Risk Factors&#8221; in this prospectus. Some of the principal risks related to our business include the following:</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 94%; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our incurrence of losses since inception;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">risks related to future acquisitions and our ability to manage our business and our results of operations and financial condition;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">risks related to outages, defects and other performance and quality problems in connection with acquired assets and businesses;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the fact that a small number of customers represent a significant percentage of our revenue;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our reliance on module manufacturers to produce the modules which we then sell to our customers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">risks incident to operating internationally;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 94%; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to protect our intellectual property rights;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our dependence upon the timely delivery of products from our vendors and purchases from our partners and customers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">real or perceived errors, failures or bugs in our modules;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the seasonal nature of our operations;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general economic downturns and the potential for declines in discretionary consumer spending;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to maintain the listing of our common stock on the Nasdaq Capital Market; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will have broad discretion as to the proceeds that we receive from the cash exercise by any holder of the Warrants, and we may not use the proceeds effectively;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You may experience future dilution as a result of issuance of the Warrant Shares, future equity offerings by us and other issuances of our Common Stock or other securities. In addition, the issuance of the Warrant Shares and future equity offerings and other issuances of our Common Stock or other securities may adversely affect our Common Stock price; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other risks set forth in &#8220;Risk Factors&#8221; below.</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
Information</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal executive office is located at 15268 NW Greenbrier Pkwy, Beaverton, Oregon 97006 and our telephone number is (408) 627-4716.
Our website address is&#160;<I>www.datavaultsite.com</I>. The website for our associated brands, manufacturers and influencers within
the consumer electronics industry is&#160;<I>http://www.wisaassociation.org</I>. The information contained on, or that can be accessed
through, our websites is not incorporated by reference into this prospectus and is intended for informational purposes only.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
information about us is included in documents incorporated by reference in this prospectus. See &#8220;Where You Can Find More Information&#8221;
and &#8220;Information Incorporated by Reference.&#8221;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_005"></A>ABOUT
THIS OFFERING</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus relates to the offer and resale by the Selling Stockholders of up to 22,728,368 shares of Common Stock. All of the Warrant
Shares, if and when sold, will be sold by the Selling Stockholders. The Selling Stockholders may sell the Warrant Shares from time to
time at prevailing market prices or at privately negotiated prices.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares offered by the Selling Stockholders:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 73%; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up to 22,728,368 shares of Common Stock.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of Common Stock outstanding after completion of this offering (assuming full exercise of the Warrants that are exercisable for the Warrant Shares offered hereby):</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107,390,677 <SUP>(1)</SUP>&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of proceeds:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will not receive any of the proceeds from any sale of the Warrant Shares by the Selling Stockholders. We may receive up to $23,768,041 in gross proceeds from cash exercises of the Warrants, if exercised in full, based on the per share exercise price of $2.21 for the September&#160;2024 Warrants, $1.425 for the Placement Agent Warrants and $0.8615 for the 2025 Investor Warrants and assuming that all exercises of the Warrants will be effected on a cash basis. The exercise price for the 2025 Investor Warrants may be adjusted downwards pursuant to the terms of anti-dilution features contained therein under certain circumstances, and if any of the 2025 Investor Warrants are exercised at such lower price, we will receive less aggregate gross proceeds. If the Warrants are exercised pursuant to the cashless exercise provisions contained therein, we will also receive less aggregate gross proceeds. &#160;Any proceeds that we receive from the exercise of the Warrants will be used for working capital, capital expenditures, product development, and other general corporate purposes, including investments in sales and marketing in the United States and internationally. See &#8220;Use of Proceeds.&#8221;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk factors:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An investment in our securities involves substantial risk. You should read carefully the &#8220;Risk Factors&#8221; section on page&#160;6 of this prospectus, and under similar headings in the other documents incorporated by reference into this prospectus. Additional risks and uncertainties not presently known to us or that we currently deem to be immaterial may also impair our business and operations.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq symbol for Common Stock:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;DVLT&#8221;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="width: 97%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Shares of our Common Stock that will be outstanding after this offering is based on 84,662,309 shares of Common Stock outstanding as of July 2, 2025, but excludes the following as of such date: (i)&nbsp;31,232,173 shares of Common Stock issuable upon exercise of outstanding Common Stock purchase warrants, (ii)&nbsp;1,150,014 shares of Common Stock underlying issued and unvested restricted stock units (&ldquo;RSUs&rdquo;), (iii) 7,846,933 shares of Common Stock underlying restricted stock awards subject to time based vesting granted pursuant to our 2018 Long-term Incentive Plan (the &ldquo;LTIP&rdquo;) and 1,955,000 shares of Common Stock underlying restricted stock awards subject to performance conditions granted pursuant to the LTIP, (iv)&nbsp;up to an aggregate of 1,750 shares of Common Stock issuable upon conversion of all outstanding shares of Series&nbsp;B Convertible Preferred Stock, par value $0.0001 per share (&ldquo;Series&nbsp;B Preferred Stock&rdquo;) (which shares of Series&nbsp;B Preferred Stock assume the exercise of all 1,750 Series&nbsp;B Preferred Stock purchase warrants), (v)&nbsp;5,000,000 shares of Common Stock issuable pursuant to the Share Exchange Agreement (the &ldquo;NYIAX Share Agreement&rdquo;) between the Company and NYIAX,&nbsp;Inc. (&ldquo;NYIAX&rdquo;) and (vi)&nbsp;shares of Common Stock issuable under the Notes (defined below) issued pursuant to the Purchase Agreement. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_006"></A>RISK
FACTORS</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>An
investment in the securities offered under this prospectus involves a high degree of risk. You should carefully consider and evaluate
all of the information contained in this prospectus and in the documents that we incorporate by reference herein before you decide to
invest in our securities. In particular, you should carefully consider and evaluate the risks and uncertainties described under the heading
 &#8220;Risk Factors&#8221; in this prospectus and in the documents incorporated by reference herein. Investors are further advised that
the risks described below may not be the only risks we face. Additional risks that we do not yet know of, or that we currently think
are immaterial, may also negatively impact our business operations or financial results. Any of the risks and uncertainties set forth
in this prospectus and in the documents incorporated by reference herein, as updated by annual, quarterly and other reports and documents
that we file with the SEC and incorporate by reference into this prospectus, could materially and adversely affect our business, results
of operations and financial condition, which in turn could materially and adversely affect the value of our securities.</I></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Financial Condition</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
revenue and loss from operations forecasts are subject to change as a result of a variety of risks and uncertainties.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
revenue and loss from operations forecasts can change as a result of a variety of factors including but are not limited to changes in
sales levels, unexpected increases in product costs and increases in operating costs. Significant changes from our current forecasts,
including but not limited to: (i)&#160;shortfalls from projected sales levels; (ii)&#160;unexpected increases in product costs; (iii)&#160;increases
in operating costs; and (iv)&#160;inability to regain and maintain compliance with the Nasdaq continued listing requirements, could have
a material adverse impact on our ability to access the level of funding necessary to continue our operations at current levels. If any
of these events occurs or if we are not able to secure additional funding, we may be forced to make reductions in spending, liquidate
assets where possible, and/or suspend or curtail planned programs. Any of these actions could materially harm our business, revenues,
results of operations and future prospects.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
need financing in the near term to support our ongoing operations. If we do not raise sufficient capital in the short term, we may be
forced to cease operations, liquidate our assets and possibly seek bankruptcy protection or engage in a similar process.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently operating at a loss and our cash position is insufficient to fund operations in the near term. As such,&#160;we need additional
financing to implement our business plan and to service our ongoing operations.&#160;We believe that current cash on hand, prior to the
receipt of any proceeds from the exercise of the Warrants, is not sufficient to fund our immediate operational needs.&#160;There can
be no assurance that we will be able to secure any needed funding, or that if such funding is available, the terms or conditions would
be acceptable to us. If we are unable to obtain additional financing in the short term, we will be required to divest all or a portion
of our business or otherwise liquidate, wind-up, restructure or curtail our operations and product development timeline.&#160;We may
seek additional capital through a combination of equity offerings, such as this offering, debt financings and/or strategic collaborations.
If such financing is not available on satisfactory terms, or is not available at all, our ability to accelerate product development will
be hindered, our business and financial condition may be materially and adversely affected, and you may lose all or part of your investment.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have incurred losses since inception.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have incurred net losses since inception and had an accumulated deficit of approximately $308.0 million as of March&#160;31, 2025. If
we are unsuccessful in implementing any initiatives to improve our revenues to achieve profitability, it will have a material adverse
impact on our business, prospects, operating results and financial condition. There can be no assurance that the revenue that we generate
will be able to support our operations or meet our working capital needs.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
independent registered public accounting firm&#8217;s report contains an explanatory paragraph that expresses substantial doubt about
our ability to continue as a going concern.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
independent registered public accounting firm has included in its report for the year ended December&#160;31, 2024 an explanatory paragraph
expressing substantial doubt about our ability to continue as a going concern. Our consolidated financial statements have been prepared
on a going concern basis, which contemplates the realization of assets and the discharge of liabilities in the normal course of business.
Our ability to continue as a going concern is contingent upon, other factors, our ability to raise additional capital through sales of
our securities, including this offering, and incurrence of debt. Additionally, future capital requirements will depend on many factors,
including the rate of revenue growth, the selling price of our products, the expansion of sales and marketing activities, the timing
and extent of spending on research and development efforts and the continuing market acceptance of our products. These factors raise
substantial doubt about our ability to continue as a going concern. There is no assurance that additional financing will be available
at terms acceptable to us or at all. If we cannot continue as a viable entity, this could materially adversely affect the value of the
shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Business and Industry</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Legacy
Datavault (as defined below) has a limited operating history, which makes it difficult to forecast our future results of operations.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the limited operating history of Data Vault Holdings Inc. (&#8220;Legacy Datavault&#8221;), our ability to accurately forecast
future results from the operations of the Legacy Datavault business is limited and subject to a number of uncertainties, including our
ability to plan for and model future growth. Further, in future periods, our revenue growth from the Legacy Datavault business could
slow or its revenue could decline for a number of reasons, including slowing demand for its platform, increased competition, changes
to technology, a decrease in the growth of its overall market, or its failure, for any reason, to continue to take advantage of growth
opportunities. We have also encountered, and will continue to encounter, risks and uncertainties frequently experienced by growing companies
in rapidly changing industries, such as the risks and uncertainties described below. If our assumptions regarding these risks and uncertainties
and its future revenue growth are incorrect or change, or if we do not address these risks successfully, our operating and financial
results could differ materially from our expectations, and our business could suffer.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may not have visibility into our financial position and results of operations.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the future, customers will consume our platform through license and the use of our software as a service platform for the data refinery,
meta data layer creation, and through the monetization of data assets. Because prospective customers have flexibility in the timing of
their consumption, we may not have the visibility into the timing of revenue recognition that a typical subscription-based software company
has. There is a risk that customers will consume our platform more slowly than we expect, and our actual results may differ from our
forecasts. Further, investors and securities analysts may not understand how our consumption-based business model differs from a subscription-based
business model, and our business model may be compared to subscription-based business models.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Sales
efforts to large customers involve risks that may not be present or that are present to a lesser extent with respect to sales to smaller
organizations.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
to large customers involve risks that may not be present or that are present to a lesser extent with sales to smaller organizations,
such as longer sales cycles, more complex customer requirements, substantial upfront sales costs, and less predictability in completing
some of our sales. For example, large customers may require considerable time to evaluate and test our platform prior to making a purchase
decision and placing an order. A number of factors influence the length and variability of our sales cycle, including the need to educate
potential customers about the uses and benefits of our platform, the discretionary nature of purchasing and budget cycles, and the competitive
nature of evaluation and purchasing approval processes. As a result, the length of our sales cycle, from identification of the opportunity
to deal closure, may vary significantly from customer to customer, with sales to large enterprises typically taking longer to complete.
Moreover, large customers often begin to deploy our products on a limited basis but nevertheless demand implementation services and negotiate
pricing discounts, which increase our upfront investment in the sales effort with no guarantee that sales to these customers will justify
our substantial upfront investment. If we fail to effectively manage these risks associated with sales cycles and sales to large customers,
our business, financial condition, and results of operations may be affected.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>A
small number of customers represent a significant percentage of our revenue, so any loss of key customers could have a material adverse
effect on our business.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
small number of our customers represent a significant percentage of our revenue. Although we may have agreements with these customers,
these agreements typically do not require any minimum purchases and do not prohibit customers from using competing technologies or customers
from purchasing products and services from competitors. Because many of our markets are rapidly evolving, customer demand for our technologies
and products can shift quickly.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December&#160;31, 2024, the Company had&#160;three&#160;customers accounting for&#160;68%, 12%, and 11% of accounts receivable. As
of December&#160;31, 2023, the Company had&#160;two&#160;customers accounting for&#160;71% and&#160;20% of accounts receivable. The Company
had&#160;four&#160;customers accounting for&#160;29%,&#160;19%,&#160;18% and&#160;10% of its net revenue for the year ended December&#160;31,
2024. The Company had&#160;four&#160;customers accounting for&#160;25%,&#160;19%,&#160;14% and&#160;13% of its net revenue for the year
ended December&#160;31, 2023.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
loss of any of our key customers could have a material adverse effect on our business and results of operations.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are reliant on module manufacturers to produce the modules which we then sell to our customers and any change in their management or
business could have a negative effect on our operations.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
revenue from the sale of modules to consumer electronics and speaker companies depends in large part upon the availability of our modules
that implement our technologies. Our manufacturers incorporate our technologies into these modules, which are then incorporated in consumer
entertainment products. We do not manufacture these modules, but rather depend on manufacturers to produce the modules which we then
sell to our customers. We do not control the manufacturers. While we have a longstanding relationship with our manufacturers, there can
be no assurance that our manufacturers will continue to timely produce our modules. Change in management of our manufacturers or a change
in their operations could negatively affect our production and cause us to seek other manufacturers which we may not be able to obtain
on the same or similar terms as our current manufacturers. This could have a negative effect on our operations.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
currently rely on semiconductor manufacturers to manufacture our semiconductors, and our failure to manage our relationship with our
semiconductor manufacturers successfully could negatively impact our business.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on a single contractor in Japan for the production of our transmit semiconductor chip and a single contractor in China for the production
of our receive semiconductor chip. Our reliance on these semiconductor manufacturers reduces our control over the manufacturing process,
exposing us to risks, including increase production costs and reduced product supply. If we fail to manage our relationships with these
manufacturers effectively, or if a contract manufacturer experiences delays, disruptions, or decides to end-of-life components that it
manufactures for us, our ability to ship products to our end-user customers could be impaired and our competitive position and reputation
could be harmed. In addition, any adverse change in our manufacturers&#8217; financial or business condition could disrupt our ability
to supply quality products to our end-user customers. If we are required to change manufacturers, we may lose revenue, incur increased
costs and damage our customer relationships. In addition, qualifying a new semiconductor manufacturer and commencing production can be
an expensive and lengthy process. As a result of any of these aforementioned disruptions, we would experience a delay in our order fulfillment,
and our business, operating results and financial condition would be adversely affected.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Declines
in or problems with the WiSA Association membership could negatively affect our reputation.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
wholly owned subsidiary, WiSA, LLC, operates the &#8220;WiSA Association,&#8221; which is an association comprised of brands, manufacturers,
and influencers within the consumer electronics industry, with the purpose of promoting a standardized method of interoperability between
wireless audio components using our technology. We rely significantly on the WiSA Association to uphold the standards and criteria of
interoperable audio products. If we lose members or new technology is developed that is easier to incorporate than ours, the WiSA Association
may fail to maintain its active status and the sales of our modules could diminish as well. In addition, failure of our members to adhere
to our policies designed to provide interoperability between audio systems could undermine the integrity of our brand.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Failure
to stay on top of technology innovation could harm our business model.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
revenue growth will depend upon our success in new and existing markets for our technologies. The markets for our technologies and products
are defined by:</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 97%; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">rapid technological change;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">new and improved technology and frequent product introductions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">consumer demands; evolving industry standards; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">technology and product obsolescence.</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future success depends on our ability to enhance our technologies and products and to develop new technologies and products that address
the market needs in a timely manner. Technology development is a complex, uncertain process requiring high levels of innovation, highly
skilled engineering and development personnel, and the accurate anticipation of technological and market trends. We may not be able to
identify, develop, acquire, market, or support new or enhanced technologies or products on a timely basis, if at all.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Failure
to effectively develop and expand our sales and marketing capabilities could harm our ability to increase our customer base and achieve
broader market acceptance of our modules.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
increase total customers and customer recognition of the WiSA Association products and to achieve broader market acceptance of our technology,
we will need to expand our sales and marketing organization and increase our business development resources, including the vertical and
geographic distribution of our sales force and our teams of account executives focused on new accounts and responsible for renewal and
growth of existing accounts.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business requires that our sales personnel have particular expertise and experience in interoperability of audio systems, and the latest
wireless audio technology. We may not achieve revenue growth from expanding our sales force if we are unable to hire, develop and retain
talented sales personnel with appropriate experience, if our new sales personnel are unable to achieve desired productivity levels in
a reasonable period of time or if our sales and marketing programs are not effective.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Interruptions
or performance problems associated with technology and wireless technology outside of our control may adversely affect our business and
results of operations.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may in the future experience performance issues due to a variety of factors, including wireless technology disruptions, human or software
errors. If a wireless connection is compromised, our products will not work as designed and our business could be negatively affected.
In some instances, we may not be able to identify the cause or causes of these performance problems within an acceptable period or a
connection problem may be out of our control and could deter customers from purchasing wireless audio components.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to continue to make significant investments to maintain and improve the performance of our modules. To the extent that we do not
effectively address capacity constraints, upgrade our systems as needed and continually develop our technology to accommodate actual
and anticipated changes in technology, our business, operating results and financial condition may be adversely affected.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Real
or perceived errors, failures or bugs in our modules could adversely affect our operating results and growth prospects.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
our modules are complex, undetected errors, failures or bugs may occur. Our module is installed and used in numerous audio systems of
different brands with different operating systems, system management software, and equipment and networking configurations, which may
cause errors or failures of our technology. Despite our testing, errors, failures or bugs may not be found in our modules until it is
released to our customers. Moreover, our customers could incorrectly implement or inadvertently misuse our modules, which could result
in customer dissatisfaction and adversely impact the perceived quality or utility of our products as well as our brand.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
of these real or perceived errors, compatibility issues, failures or bugs in our modules could result in negative publicity, reputational
harm, loss of competitive position or claims by customers for losses sustained by them. In such an event, we may be required, or may
choose, for customer relations or other reasons, to expend additional resources to correct the problem. Alleviating any of these problems
could require significant expenditures of our capital and other resources and could cause interruptions or delays in the use of our solutions,
which could cause us to lose existing or potential customers and could adversely affect our operating results and growth prospects.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
rely on the cooperation of our customers to install our modules in their audio products.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
modules are sold to our customers who are consumer electronics companies. Our customers install the modules into their products. Our
customers&#8217; audio products are sold to the public who must then install the audio system into their homes or businesses. We do not
oversee installation of our products and therefore have no control over the result. If a module is not installed correctly in a customer
product or an end consumer does not install their audio system correctly, our technology may not work properly, which could result in
customer dissatisfaction or have a material adverse impact on our reputation, our business and our financial results.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we do not or cannot maintain cutting edge technology and compatibility of our modules with products that our customers use, our business
could suffer.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
customers integrate our modules into their products. The functionality and popularity of our technology depends, in part, on our ability
to produce modules that integrate into our customers&#8217; products. Our customers may change the features of their technologies and
audio systems may advance technologically. Such changes or advancements could functionally limit or terminate the utility of our product,
which could negatively impact our customer service and harm our business. If we fail to maintain cutting edge technology and compatibility
with the products our customers produce, we may not be able to offer the functionality that our customers need, and our customers may
not purchase our modules, which would negatively impact our ability to generate revenue and have a material adverse impact on our business.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
future quarterly results of operations may fluctuate significantly due to a wide range of factors, which makes our future results difficult
to predict.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
revenues and results of operations could vary significantly from quarter to quarter because of various factors, many of which are outside
of our control, including:</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 97%; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the expansion of our customer base;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the recent acquisition of certain assets pursuant to the Asset Purchase Agreement (as defined below);</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 36pt">&nbsp;</P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 97%; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the renewal of agreements with, and expansion of coverage by, existing customers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the size, timing and terms of our sales to both existing and new customers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the introduction of products or services that may compete with us for the limited funds available to our customers, and changes in the cost of such products or services;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in our customers&#8217; and potential customers&#8217; budgets;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to control costs, including our operating expenses;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to hire, train and maintain our direct sales force, engineers, and marketing employees;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the timing of satisfying revenue recognition criteria in connection with initial deployment and renewals;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general economic and political conditions, both domestically and internationally; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the effects of outbreaks, epidemics or pandemics of contagious diseases.</FONT></TD></TR>
  </TABLE>



<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
one of these or other factors discussed elsewhere in this prospectus, or the documents incorporated by reference herein, may result in
fluctuations in our revenues and operating results, meaning that quarter-to-quarter comparisons of our revenues, results of operations
and cash flows may not necessarily be indicative of our future performance.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
of the fluctuations described above, our ability to forecast revenues is limited and we may not be able to accurately predict our future
revenues or results of operations. In addition, we base our current and future expense levels on our operating plans and sales forecasts,
and our operating expenses are expected to be relatively fixed in the short term. Accordingly, we may not be able to reduce our costs
sufficiently to compensate for an unexpected shortfall in revenues, and even a small shortfall in revenues could disproportionately and
adversely affect our financial results for that quarter. The variability and unpredictability of these and other factors could result
in our failing to meet or exceed financial expectations for a given period.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
sales are subject to fluctuation as a result of seasonality, which is outside of our control.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
sales are subject to the seasonality of when consumers buy electronic products, generally in the third quarter leading up to the year-end
holiday season. Our customers&#8217; plans to complete and ship new products to meet this seasonal peak can critically impact our financial
results should they miss the holiday season. As a result of these factors, our financial results for any single quarter or for periods
of less than a year are not necessarily indicative of the results that may be achieved for a full fiscal year.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
sales are subject to fluctuation as a result of our customers&#8217; new product introduction timelines and end-user adoption of our
customers&#8217; retail products, both of which are outside of our control.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We,
in conjunction with our customers, are launching a new technology to the retail and consumer market. The consumer adoption rate at retail
is a critical component of our financial success and is currently an unknown component of our financial plans. The variability and unpredictability
of these and other factors could result in our failing to meet or exceed financial expectations for a given period. As a result of these
factors, our financial results for any single quarter or for periods of less than a year are not necessarily indicative of the results
that may be achieved for a full fiscal year.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
conduct international operations, which exposes us to significant risks.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
headquarters are located in Oregon, but we also have employees in Taiwan and Korea and representatives in China and Japan. Operating
in international markets requires significant resources and management attention and subjects us to regulatory, economic and political
risks in addition to those we already face in the United States. In addition, we invest time and resources in understanding the regulatory
framework and political environments of our customers overseas in order to focus our sales efforts. Because such regulatory and political
considerations are likely to vary across jurisdictions, this effort requires additional time and attention from our sales team and could
lead to a sales cycle that is longer than our typical process for sales in the United States. We also may need to hire additional employees
and otherwise invest in our international operations in order to reach new customers. Because of our limited experience with international
operations as well as developing and managing sales in international markets, our international efforts may not be successful.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we will face risks in doing business internationally that could adversely affect our business, including:</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 97%; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the potential impact of currency exchange fluctuations;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the difficulty of staffing and managing international operations and the increased operations, travel, shipping and compliance costs associated with having customers in numerous international locations;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">potentially greater difficulty collecting accounts receivable and longer payment cycles;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the need to offer customer support in various languages;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">challenges in understanding and complying with local laws, regulations and customs in foreign jurisdictions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">export controls and economic sanctions administered by the Department of Commerce Bureau of Industry and Security and the Treasury Department&#8217;s Office of Foreign Assets Control;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">compliance with various anti-bribery and anti-corruption laws such as the Foreign Corrupt Practices Act and United Kingdom Bribery Act of 2010;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">tariffs and other non-tariff barriers, such as quotas and local content rules;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">more limited protection for our intellectual property in some countries;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">adverse or uncertain tax consequences as a result of international operations;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">currency control regulations, which might restrict or prohibit our conversion of other currencies into U.S. dollars;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions on the transfer of funds;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">deterioration of political relations between the United States and other countries; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">political or social unrest or economic instability in a specific country or region in which we operate, which could have an adverse impact on our operations in that location.</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also,
we expect that due to costs related to our international efforts and the increased cost of doing business internationally, we will incur
higher costs to secure sales to international customers than the comparable costs for domestic customers. As a result, our financial
results may fluctuate as we expand our operations and customer base worldwide.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
failure to manage any of these risks successfully could harm our international operations and adversely affect our business, operating
results and financial condition.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are dependent on the continued services and performance of our senior management and other key personnel, the loss of any of whom could
adversely affect our business.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future success depends in large part on the continued contributions of our senior management and other key personnel. In particular,
the leadership of key management personnel is critical to the successful management of our Company, the development of our products,
and our strategic direction. We also depend on the contributions of key technical personnel.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not maintain &#8220;key person&#8221; insurance for any member of our senior management team or any of our other key employees. Our
senior management and key personnel are all employed on an at-will basis, which means that they could terminate their employment with
us at any time, for any reason and without notice. The loss of any of our key management personnel could significantly delay or prevent
the achievement of our development and strategic objectives and adversely affect our business.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Cyber-security
incidents, including data security breaches or computer viruses, could harm our business by disrupting our delivery of products or services,
damaging our reputation or exposing us to liability.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
receive, process, store and transmit, often electronically, the data of our customers and others, much of which is confidential. Unauthorized
access to our computer systems or stored data could result in the theft, including cyber-theft, or improper disclosure of confidential
information, and the deletion or modification of records could cause interruptions in our operations. These cyber-security risks increase
when we transmit information from one location to another, including over the Internet or other electronic networks. Despite the security
measures we have implemented, our facilities, systems and procedures, and those of our third-party service providers, may be vulnerable
to security breaches, acts of vandalism, software viruses, misplaced or lost data, programming or human errors or other similar events
which may disrupt our delivery of services or expose the confidential information of our customers and others. Any security breach involving
the misappropriation, loss or other unauthorized disclosure or use of confidential information of our customers or others, whether by
us or a third party, could subject us to civil and criminal penalties, have a negative impact on our reputation, or expose us to liability
to our customers, third parties or government authorities. We are not aware of such breaches to date. There can be no assurance that
we will be able to effectively handle a failure of our information systems, or that we will be able to restore our operational capacity
in a timely manner to avoid disruption to our business. Any of these developments could have a material adverse effect on our business,
financial condition and results of operations.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
obligations in connection with our senior secured promissory notes could restrict our operating and financial flexibility which could
impair our liquidity and thereby harm our business, results of operations and financial condition.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April&#160;3, 2025, the Company issued senior secured convertible notes (the &#8220;Initial Notes&#8221;) having an aggregate principal
amount of $5,555,555 for an aggregate purchase price of $5,000,000 in connection with the Purchase Agreement. On May&#160;19, 2025, the
Company issued additional notes having an aggregate principal amount of $11,111,111 (the &#8220;Additional Notes&#8221; and with the
Initial Notes, the &#8220;Notes&#8221;). The Notes carry a 10% original issue discount, and mature 18 months from the date of issuance.
The Notes are secured by all of the assets of the Company and the Company&#8217;s obligation under the Notes are guaranteed by the domestic
subsidiaries of the Company and rank senior to all other existing indebtedness and equity of the Company.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Notes, so long as the Notes are outstanding, the Company is not permitted to, among other things and without prior written consent
of the holders of the Notes, (i)&#160;incur any debt, (ii)&#160;repurchase, repay, or offer to repay or repurchase more than a de minimis
number of shares of Common Stock or common stock equivalents, or (iii)&#160;sell, assign, transfer or otherwise dispose of any of its
assets, in each case subject to limited exceptions. The Notes, while not carrying any interest, include certain events of default which
would trigger a 12% default interest rate that would begin to accrue upon such an event of default.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
limitations on our ability to operate, combined with our other financial obligations, could increase our vulnerability to adverse changes
in general economic, industry and market conditions, limit our flexibility in planning for, or reacting to, changes in our business and
the industry and impose a competitive disadvantage compared to our competitors that have less debt or are otherwise not subject to similar
restrictions on operating.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, because the Notes are secured by all of our assets, should we default on our obligations under the Notes the holders of such
Notes are entitled to receive the value of the Notes out of our assets. Such transfer of our assets to the holders of the Notes could
result in our ability to continue to operate our business being severely limited or our inability to continue to operate our business
in part or entirely.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Future
acquisitions may have a material adverse effect on our ability to manage our business and our results of operations and financial condition.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may acquire businesses, technologies, services, or products which are complementary to our business. Future acquisitions, such as the
currently contemplated acquisition pursuant to the asset purchase agreement with CompuSystems Inc (the &#8220;CSI Agreement&#8221;),
may expose us to potential risks, including risks associated with&#160;the integration of new operations, services, and personnel, unforeseen
or hidden liabilities, the diversion of resources and management attention from our existing business and technology, our potential inability
to generate sufficient revenue to offset new costs, the costs and expenses incurred in connection with such acquisitions, or the potential
loss of or harm to relationships with suppliers, employees, and customers resulting from our integration of new businesses.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
of the potential risks listed above could have a material adverse effect on our ability to manage our business or our results of operations
and financial condition. In addition, we may need to fund any such acquisitions through the incurrence of additional debt or the sale
of additional debt or equity securities, which would result in increased debt service obligations, including additional operating and
financing covenants, or liens on our assets, that would restrict our operations, or dilution to our shareholders.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Changes
in financial accounting standards may cause adverse and unexpected revenue fluctuations and impact our reported results of operations.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
change in accounting standards or practices could harm our operating results and may even affect our reporting of transactions completed
before the change is effective. New accounting pronouncements and varying interpretations of accounting pronouncements have occurred
and may occur in the future. Changes to existing rules&#160;or the questioning of current practices may harm our operating results or
the way we conduct our business.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Climate
change may have a long-term impact on our business.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Climate
change may have an increasingly adverse impact on our business and those of our customers and suppliers. Water and energy availability
and reliability in the communities where we conduct business is critical. Climate change, its impact on our supply chain and critical
infrastructure worldwide, and its potential to increase political instability in regions where we, our customers and suppliers do business,
may disrupt our business and may cause us to experience higher attrition, losses and costs to maintain or resume operations. Although
we maintain a program of insurance coverage for a variety of property, casualty, and other risks, the types and amounts of insurance
we obtain vary depending on availability and cost. Some of our policies have large deductibles and broad exclusions, and our insurance
providers may be unable or unwilling to pay a claim. Losses not covered by insurance may be large, which could harm our results of operations
and financial condition.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations, products and services, as well as those of our suppliers and customers, may also be subject to climate-related laws, regulations
and lawsuits. Regulations such as carbon taxes, fuel or energy taxes, and pollution limits could result in greater direct costs, including
costs associated with changes to manufacturing processes or the procurement of raw materials used in manufacturing processes, increased
levels of capital expenditures to improve facilities and equipment, and higher compliance and energy costs to reduce emissions, as well
as greater indirect costs resulting from our customers, suppliers or both incurring additional compliance costs that are passed on to
us. These costs and restrictions could harm our business and results of operations by increasing our expenses or requiring us to alter
our operations and product design activities. Stockholder groups may find us insufficiently responsive to the implications of climate
change, and therefore we may face legal action or reputational harm. We may also experience contractual disputes due to supply chain
delays arising from climate change-related disruptions, which could result in increased litigation and costs.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also face risks related to business trends that may be influenced by climate change concerns. Stockholder advocacy groups, certain institutional
investors, investment funds, other market participants, stockholders and customers have focused increasingly on the environmental, social
and corporate governance (&#8220;ESG&#8221;), and sustainability practices of companies, including those associated with climate change
and human rights. These parties have placed increased importance on the implications of the social cost of their investments. If our
ESG practices do not meet stockholder or other industry expectations and standards, which continue to evolve, our brand, reputation and
business activities may be negatively impacted. Any sustainability disclosures we make may include our policies and practices on a variety
of social and ethical matters, including corporate governance, environmental compliance, employee health and safety practices, human
capital management, product quality, supply chain management, and talent diversity and inclusion practices. It is possible that our stockholders
may not be satisfied with our ESG practices or the speed of their adoption. We could also incur additional costs and require additional
resources to monitor, report, and comply with various ESG practices, or choose not to conduct business with potential customers, or discontinue
or not expand business with existing customers, due to our policies. Also, our failure, or perceived failure, to meet the standards included
in any sustainability disclosure could have a material negative impact on our reputation and business activities.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
face intense competition in our industry, and we may not be able to compete successfully in our target markets.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
digital audio, consumer electronics and entertainment markets are characterized by intense competition, subject to rapid change, and
are significantly affected by new product introductions and other market activities of industry participants. Our competitors include
many large domestic and international companies that have substantially greater financial, technical, marketing, distribution and other
resources, greater name recognition, a longer operating history, broader product lines, lower cost structures and longer-standing relationships
with customers and suppliers than we do. As a result, our competitors may be able to respond better to new or emerging technologies or
standards and to changes in customer requirements.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
some of our competitors are in a better financial and marketing position from which to influence industry acceptance of a particular
product standard or a competing technology than we are. Our competitors may also be able to devote greater resources to the development,
promotion and sale of products, and may be in a position to deliver competitive products at a lower price than we can, along with the
potential to conduct strategic acquisitions, joint ventures, subsidies and lobbying industry and government standards, hire more experienced
technicians, engineers and research and development teams than we can. As a result, we may not be able to compete effectively against
any of these organizations.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to compete in our current target markets and future markets will depend in large part on our ability to successfully develop,
introduce and sell new and enhanced products or technologies on a timely and cost-effective basis and to respond to changing market requirements.
We expect our competitors to continue to improve the performance of their current products and potentially reduce their prices. In addition,
our competitors may develop future generations and enhancements of competitive products or new or enhanced technologies that may offer
greater performance and improved pricing or render our technologies obsolete. If we are unable to match or exceed the improvements made
by our competitors, our market position and prospects could deteriorate and our net product sales could decline.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Intellectual Property</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Failure
to protect our intellectual property rights could adversely affect our business.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success depends, in part, on our ability to protect proprietary methods and technologies that we develop or license under patent and
other intellectual property (&#8220;IP&#8221;) laws of the United States, so that we can prevent others from using our inventions and
proprietary information. If we fail to protect our IP rights adequately, our competitors might gain access to our technology, and our
business might be adversely affected. However, defending our IP rights might entail significant expenses. Any of our patent rights, copyrights,
trademarks or other IP rights may be challenged by others, weakened or invalidated through administrative process or litigation.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March&#160;31, 2025, we had 25 issued and 36 pending U.S. patents covering our technology. We also license issued U.S. patents from
others. The patents that we own or license from others (including those that may be issued in the future) may not provide us with any
competitive advantages or may be challenged by third parties, and our patent applications may never be granted.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the process of obtaining patent protection is expensive and time-consuming, and we may not be able to prosecute all necessary or desirable
patent applications at a reasonable cost or in a timely manner. Even if issued, there can be no assurance that these patents will adequately
protect our IP, as the legal standards relating to the validity, enforceability and scope of protection of patent and other IP rights
are uncertain.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
patents that are issued may subsequently be invalidated or otherwise limited, allowing other companies to develop offerings that compete
with ours, which could adversely affect our competitive business position, business prospects and financial condition. In addition, issuance
of a patent does not guarantee that we have a right to practice the patented invention. Patent applications in the United States are
typically not published until 18 months after filing or, in some cases, not at all, and publications of discoveries in industry-related
literature lag behind actual discoveries. We cannot be certain that third parties do not have blocking patents that could be used to
prevent us from marketing or practicing our patented software or technology.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
patent, trademark, copyright and trade secret protection may not be available to us in every country in which our software is available.
The laws of some foreign countries may not be as protective of IP rights as those in the United States (in particular, some foreign jurisdictions
do not permit patent protection for software), and mechanisms for enforcement of IP rights may be inadequate. Additional uncertainty
may result from changes to IP legislation enacted in the United States, including the recent America Invents Act, and other national
governments and from interpretations of the IP laws of the United States and other countries by applicable courts and agencies. Accordingly,
despite our efforts, we may be unable to prevent third parties from infringing upon or misappropriating our IP.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely in part on trade secrets, proprietary know-how and other confidential information to maintain our competitive position. Although
we endeavor to enter into non-disclosure agreements with our employees, licensees and others who may have access to this information,
we cannot assure you that these agreements or other steps we have taken will prevent unauthorized use, disclosure or reverse engineering
of our technology. Moreover, third parties may independently develop technologies or products that compete with ours, and we may be unable
to prevent this competition.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
might be required to spend significant resources to monitor and protect our IP rights. We may initiate claims or litigation against third
parties for infringement of our proprietary rights or to establish the validity of our proprietary rights. Litigation also puts our patents
at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing. Additionally, we may provoke
third parties to assert counterclaims against us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies
awarded, if any, may not be commercially viable. Any litigation, whether or not resolved in our favor, could result in significant expense
to us and divert the efforts of our technical and management personnel, which may adversely affect our business, operating results, financial
condition and cash flows.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may be subject to IP rights claims by third parties, which are extremely costly to defend, could require us to pay significant damages
and could limit our ability to use certain technologies.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Companies
in the software and technology industries, including some of our current and potential competitors, own large numbers of patents, copyrights,
trademarks and trade secrets and frequently enter into litigation based on allegations of infringement or other violations of IP rights.
In addition, many of these companies have the capability to dedicate substantially greater resources to enforce their IP rights and to
defend claims that may be brought against them. The litigation may involve patent holding companies or other adverse patent owners that
have no relevant product revenues and against which our patents may therefore provide little or no deterrence. We have received, and
may in the future receive, notices that claim we have misappropriated, misused, or infringed other parties&#8217; IP rights, and, to
the extent we gain greater market visibility, we face a higher risk of being the subject of IP infringement claims.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
may be third-party IP rights, including issued or pending patents that cover significant aspects of our technologies or business methods.
Any IP claims, with or without merit, could be very time-consuming, could be expensive to settle or litigate and could divert our management&#8217;s
attention and other resources. These claims could also subject us to significant liability for damages, potentially including treble
damages if we are found to have willfully infringed patents or copyrights. These claims could also result in our having to stop using
technology found to be in violation of a third party&#8217;s rights. We might be required to seek a license for the IP, which may not
be available on reasonable terms or at all. Even if a license were available, we could be required to pay significant royalties, which
would increase our operating expenses. As a result, we may be required to develop alternative non-infringing technology, which could
require significant effort and expense. If we cannot license or develop technology for any infringing aspect of our business, we would
be forced to limit or stop sales of our software and may be unable to compete effectively. Any of these results would adversely affect
our business, operating results, financial condition and cash flows.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to the Asset Purchase</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
ability to successfully operate and grow business related to the Acquired Assets (as defined below) will be largely dependent upon the
efforts of Nathaniel Bradley, who became our Chief Executive Officer upon closing of the Asset Purchase (as defined below). The loss
of any of such key personnel could negatively impact the business and operations of the Company and its ability to grow the business
related to the Acquired Assets.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December&#160;31, 2024, pursuant to an asset purchase agreement by and between the Company and Data Vault Holdings Inc. (&#8220;Legacy
Datavault&#8221;) dated as of September&#160;4, 2024 (as amended prior to the closing of such transaction, the &#8220;Asset Purchase
Agreement&#8221;), we completed our previously announced asset purchase (the &#8220;Asset Purchase&#8221;) of information technology
assets, certain patents and trademarks (collectively, the &#8220;Acquired Assets&#8221;) from Legacy Datavault. Our ability to successfully
operate and grow business related to the Acquired Assets following the Asset Purchase will be dependent upon the efforts of Nathaniel
Bradley, who became our Chief Executive Officer upon consummation of the Asset Purchase. Although we expect Nathaniel Bradley to remain
with the Company, it is possible that we will lose some key personnel, and the loss of their services could have a material, adverse
effect on the business and operations the Company or the ability to grow the Company&#8217;s business.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Acquired Assets could suffer disruptions, outages, defects, and other performance and quality problems with its platform or with the
public cloud and internet infrastructure on which it relies.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legacy
Datavault&#8217;s business depends on our platform to be available without disruption. Legacy Datavault has experienced, and may in the
future experience, disruptions, outages, defects, and other performance and quality problems with Legacy Datavault&#8217;s platform.
Legacy Datavault has also experienced, and may in the future experience, disruptions, outages, defects, and other performance and quality
problems with the public cloud and internet infrastructure on which Legacy Datavault&#8217;s platform relies. These problems can be caused
by a variety of factors, including introductions of new functionality, vulnerabilities and defects in proprietary and open source software,
human error or misconduct, capacity constraints, design limitations, or denial of service attacks or other security-related incidents.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
if Legacy Datavault&#8217;s contractual and other business relationships with Legacy Datavault&#8217;s public cloud providers are terminated,
suspended, or suffer a material change to which we are unable to adapt, such as the elimination of services or features on which Legacy
Datavault&#8217;s business depends, we could be unable to provide Legacy Datavault&#8217;s platform and could experience significant
delays and incur additional expense in transitioning customers to a different public cloud provider.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
disruptions, outages, defects, and other performance and quality problems with Legacy Datavault&#8217;s platform or with the public cloud
and internet infrastructure on which it relies, or any material change in Legacy Datavault&#8217;s contractual and other business relationships
with Legacy Datavault&#8217;s public cloud providers, could result in reduced use of Legacy Datavault&#8217;s platform, increased expenses,
including service credit obligations, and harm to the Datavault brand and reputation, any of which could have a material adverse effect
on our business, financial condition, and results of operations.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
the Asset Purchase&#8217;s benefits do not meet the expectations of investors, stockholders or financial analysts, the market price of
our securities may decline.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the benefits of the Asset Purchase after its closing do not meet the expectations of investors or securities analysts, the market price
of our Common Stock may decline. Fluctuations in the price of our Common Stock could contribute to the loss of all or part of your investment.
If an active market for our Common Stock develops and continues, the trading price of our Common Stock following the Asset Purchase could
be volatile and subject to wide fluctuations in response to various factors, some of which are beyond our control. Any of these factors
could have a material adverse effect on your investment in our Common Stock and our Common Stock may trade at prices significantly below
the price you paid for them. In such circumstances, the trading price of our Common Stock may not recover and may experience a further
decline.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to the Resale of the Warrant Shares and Ownership of Shares of Our Common Stock</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Selling Stockholders may choose to sell the Warrant Shares at prices below the current market price.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders are not restricted as to the prices at which they may sell or otherwise dispose of the Warrant Shares covered by
this prospectus. Sales or other dispositions of the Warrant Shares below the then-current market prices could adversely affect the market
price of our Common Stock.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>A
large number of shares of Common Stock may be sold in the market following this offering, which may significantly depress the market
price of our Common Stock.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares sold in the offering will be freely tradable without restriction or further registration under the Securities Act. As
a result, a substantial number of shares of Common Stock may be sold in the public market following this offering. If there are significantly
more shares of Common Stock offered for sale than buyers are willing to purchase, then the market price of our Common Stock may decline
to a market price at which buyers are willing to purchase the offered Common Stock and sellers remain willing to sell Common Stock.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Neither
we nor the Selling Stockholders have authorized any other party to provide you with information concerning us or this offering.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should carefully evaluate all of the information in this prospectus, including the documents incorporated by reference herein and therein.
We may receive media coverage regarding our Company, including coverage that is not directly attributable to statements made by our officers,
that incorrectly reports on statements made by our officers or employees, or that is misleading as a result of omitting information provided
by us, our officers or employees. Neither we nor the Selling Stockholders have authorized any other party to provide you with information
concerning us or this offering, and recipients should not rely on this information.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
market price for our Common Stock is particularly volatile given our status as a relatively unknown company with a small and thinly traded
public float, and lack of profits, which could lead to wide fluctuations in our share price.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market for our Common Stock is characterized by significant price volatility when compared to the shares of larger, more established
companies that have large public floats, and we expect that our share price will continue to be more volatile than the shares of such
larger, more established companies for the indefinite future, although such fluctuations may not reflect a material change to our financial
condition or operations during any such period. Such volatility can be attributable to a number of factors. For example, from January&#160;1,
2021 through December&#160;31, 2021 the reported sale price of our Common Stock fluctuated between $18,890.55 and $73,163.42 per share.
From January&#160;1, 2022 through December&#160;31, 2022 the reported sale price of our Common Stock fluctuated between $1,293.85 and
$21,139.43 per share. From January&#160;1, 2023 through December&#160;31, 2023 the reported closing price of our Common Stock has fluctuated
between $15.95 and $2,400.30 per share. From January&#160;1, 2024 through March&#160;31, 2025, the reported sale price of our Common
Stock fluctuated between $0.72 and $18.10 per share. Such volatility can be attributable to a number of factors. First, as noted above,
our Common Stock is, compared to the shares of such larger, more established companies, sporadically and thinly traded. The price for
our Common Stock could, for example, decline precipitously in the event that a large number of our shares are sold on the market without
commensurate demand. Secondly, we are a speculative or &#8220;risky&#8221; investment due to our lack of profits to date. As a consequence
of this enhanced risk, more risk-adverse investors may, under the fear of losing all or most of their investment in the event of negative
news or lack of progress, be more inclined to sell their shares on the market more quickly and at greater discounts than would be the
case with the stock of a larger, more established company that has a large public float. Many of these factors are beyond our control
and may decrease the market price of our Common Stock regardless of our operating performance.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to being highly volatile, our Common Stock could be subject to wide fluctuations in response to a number of factors that are
beyond our control, including, but not limited to:</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 97%; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">variations in our revenues and operating expenses;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual or anticipated changes in the estimates of our operating results or changes in stock market analyst recommendations regarding our Common Stock, other comparable companies or our industry generally;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">market conditions in our industry, the industries of our customers and the economy as a whole;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual or expected changes in our growth rates or our competitors&#8217; growth rates;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">developments in the financial markets and worldwide or regional economies;</FONT></TD></TR>
  </TABLE>



<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 97%; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements of innovations or new products or services by us or our competitors;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements by the government relating to regulations that govern our industry;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales of our Common Stock or other securities by us or in the open market;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in the market valuations of other comparable companies; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other events or factors, many of which are beyond our control, including those resulting from such events, or the prospect of such events, including war, terrorism and other international conflicts, public health issues including health epidemics or pandemics, such as the COVID-19 pandemic, and natural disasters such as fire, hurricanes, earthquakes, tornados or other adverse weather and climate conditions, whether occurring in the United States or elsewhere, could disrupt our operations, disrupt the operations of our suppliers or result in political or economic instability.</FONT></TD></TR>
  </TABLE>



<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if the market for technology stocks or the stock market in general experiences loss of investor confidence, the trading price
of our Common Stock could decline for reasons unrelated to our business, financial condition or operating results. The trading price
of our Common Stock could also decline in reaction to events that affect other companies in our industry, even if these events do not
directly affect us. Each of these factors, among others, could harm the value of our Common Stock. In the past, following periods of
volatility in the market, securities class-action litigation has often been instituted against companies. Such litigation, if instituted
against us, could result in substantial costs and diversion of management&#8217;s attention and resources, which could materially and
adversely affect our business, operating results and financial condition.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have been notified by Nasdaq of our failure to comply with certain continued listing requirements. If we are unable to regain compliance
with all applicable continued listing requirements and standards of Nasdaq, our Common Stock could be delisted from Nasdaq.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is currently listed on Nasdaq. In order to maintain that listing, we must satisfy minimum financial and other continued
listing requirements and standards, including those regarding director independence and independent committee requirements, minimum stockholders&#8217;
equity, minimum share price, and certain corporate governance requirements. There can be no assurances that we will be able to comply
with the applicable listing standards of Nasdaq.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May&#160;6, 2025, we received a letter from the Listing Qualifications Staff of Nasdaq notifying us that we are not in compliance with
the minimum bid price requirement for continued listing on Nasdaq, as set forth under Nasdaq Listing Rule&#160;5550(a)(2)&#160;(the &#8220;Minimum
Bid Price Requirement&#8221;), because the closing bid price of the Common Stock was below $1.00 per share for the previous 30 consecutive
business days. Pursuant to Nasdaq Listing Rule&#160;5810(c)(3)(A), we were provided with a compliance period of 180 calendar days, or
until November&#160;3, 2025, to regain compliance with the Minimum Bid Price Requirement. In the event we do not regain compliance by
such date, we may be eligible for additional time to regain compliance. There can be no assurances that we will be able to regain compliance,
or, in the event we regain compliance, maintain continued compliance. If we are unable to regain or maintain compliance with the Nasdaq
continued listing requirements, our Common Stock will be delisted from Nasdaq.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that our Common Stock is delisted from Nasdaq as a result of our failure to comply with the Minimum Bid Price Requirement or
due to our failure to continue to comply with any other requirement for continued listing on Nasdaq, and is not eligible for listing
on another exchange, trading in the shares of our Common Stock could be conducted in the over-the-counter market or on an electronic
bulletin board established for unlisted securities such as the Pink Sheets or the OTC Bulletin Board. In such event, it could become
more difficult to dispose of, or obtain accurate price quotations for, our Common Stock, and it would likely be more difficult to obtain
coverage by securities analysts and the news media, which could cause the price of our Common Stock to decline further. Also, it may
be difficult for us to raise additional capital if we are not listed on a national exchange.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>In
the event that our Common Stock is delisted from Nasdaq, U.S. broker-dealers may be discouraged from effecting transactions in shares
of our Common Stock because they may be considered penny stocks and thus be subject to the penny stock rules.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC has adopted a number of rules&#160;to regulate &#8220;penny stock&#8221; that restricts transactions involving stock which is deemed
to be penny stock. Such rules&#160;include Rules&#160;3a51-1, 15g-1, 15g-2, 15g-3, 15g-4, 15g-5, 15g-6, 15g-7, and 15g-9 under the Exchange
Act. These rules&#160;may have the effect of reducing the liquidity of penny stocks. &#8220;Penny stocks&#8221; generally are equity
securities with a price of less than $5.00 per share (other than securities registered on certain national securities exchanges or quoted
on Nasdaq if current price and volume information with respect to transactions in such securities is provided by the exchange or system).
Our shares of Common Stock have in the past constituted, and may again in the future constitute, &#8220;penny stock&#8221; within the
meaning of the rules. The additional sales practice and disclosure requirements imposed upon U.S. broker-dealers for sales of penny stocks
may discourage such broker-dealers from effecting transactions in shares of our Common Stock, which could severely limit the market liquidity
of such shares of Common Stock and impede their sale in the secondary market.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. broker-dealer selling penny stock to anyone other than an established customer or &#8220;accredited investor&#8221; (generally,
an individual with a net worth in excess of $1,000,000 or an annual income exceeding $200,000, or $300,000 together with his or her spouse)
must make a special suitability determination for the purchaser and must receive the purchaser&#8217;s written consent to the transaction
prior to sale, unless the broker-dealer or the transaction is otherwise exempt. In addition, the &#8220;penny stock&#8221; regulations
require the U.S. broker-dealer to deliver, prior to any transaction involving a &#8220;penny stock&#8221;, a disclosure schedule prepared
in accordance with SEC standards relating to the &#8220;penny stock&#8221; market, unless the broker-dealer or the transaction is otherwise
exempt. A U.S. broker-dealer is also required to disclose commissions payable to the U.S. broker-dealer and the registered representative
and current quotations for the securities. Finally, a U.S. broker-dealer is required to submit monthly statements disclosing recent price
information with respect to the &#8220;penny stock&#8221; held in a customer&#8217;s account and information with respect to the limited
market in &#8220;penny stocks&#8221;.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
should be aware that, according to the SEC, the market for &#8220;penny stocks&#8221; has suffered in recent years from patterns of fraud
and abuse. Such patterns include: (i)&#160;control of the market for the security by one or a few broker-dealers that are often related
to the promoter or issuer; (ii)&#160;manipulation of prices through prearranged matching of purchases and sales and false and misleading
press releases; (iii)&#160;&#8220;boiler room&#8221; practices involving high-pressure sales tactics and unrealistic price projections
by inexperienced sales persons; (iv)&#160;excessive and undisclosed bid-ask differentials and markups by selling broker-dealers; and
(v)&#160;the wholesale dumping of the same securities by promoters and broker-dealers after prices have been manipulated to a desired
level, resulting in investor losses. Our management is aware of the abuses that have occurred historically in the penny stock market.
Although we do not expect to be in a position to dictate the behavior of the market or of broker-dealers who participate in the market,
management will strive within the confines of practical limitations to prevent the described patterns from being established with respect
to our securities.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
will have broad discretion as to the proceeds that we receive from the cash exercise by any holder of the Warrants, and we may not use
the proceeds effectively.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will not receive any of the proceeds from the sale of the Warrant Shares by the Selling Stockholders pursuant to this prospectus. We
may receive up to $23,768,041 in gross proceeds from cash exercises of the Warrants, if exercised in full, based on the per share exercise
price of $2.21 for the September&#160;2024 Warrants, $1.425 for the Placement Agent Warrants and $0.8615 for the 2025 Investor Warrants
and assuming that all exercises of the Warrants will be effected on a cash basis. The exercise price for the 2025 Investor Warrants may
be adjusted downwards pursuant to the terms of anti-dilution features contained therein under certain circumstances, and if any of the
2025 Investor Warrants are exercised at such lower price, we will receive less aggregate gross proceeds. If the Warrants are exercised
pursuant to the cashless exercise provisions contained therein, we will also receive less aggregate gross proceeds. To the extent that
we receive such proceeds, we intend to use the net proceeds from cash exercises of the Warrants for working capital, capital expenditures,
product development, and other general corporate purposes, including investments in sales and marketing in the United States and internationally.
We have considerable discretion in the application of such proceeds. You will not have the opportunity, as part of your investment decision,
to assess whether such proceeds are being used in a manner agreeable to you. You must rely on our judgment regarding the application
of the net proceeds from cash exercises of the Warrants, which may be used for corporate purposes that do not improve our profitability
or increase the price of our shares of Common Stock. Such proceeds may also be placed in investments that do not produce income or that
lose value. The failure to use such funds by us effectively could have a material adverse effect on our business, financial condition,
operating results and cash flow.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>You
may experience future dilution as a result of issuance of the Warrant Shares, future equity offerings by us and other issuances of our
Common Stock or other securities. In addition, the issuance of the Warrant Shares and future equity offerings and other issuances of
our Common Stock or other securities may adversely affect our Common Stock price.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to raise additional capital, we may in the future offer additional shares of our Common Stock or other securities convertible into
or exchangeable for our Common Stock at prices that may not be the same as the price per share as prior issuances of Common Stock. We
may not be able to sell shares or other securities in any other offering at a price per share that is equal to or greater than the price
per share previously paid by investors, and investors purchasing shares or other securities in the future could have rights superior
to existing stockholders. The price per share at which we sell additional shares of our Common Stock or securities convertible into Common
Stock in future transactions may be higher or lower than the prices per share for previous issuances of Common Stock or securities convertible
into Common Stock paid by certain investors. In addition, the exercise price of the Warrants for the Warrant Shares may be or greater
than the price per share previously paid by certain investors. You will incur dilution upon exercise of any outstanding stock options,
warrants or upon the issuance of shares of Common Stock under our equity incentive programs. In addition, the issuance of the Warrant
Shares and any future sales of a substantial number of shares of our Common Stock in the public market, or the perception that such sales
may occur, could adversely affect the price of our Common Stock. We cannot predict the effect, if any, that market sales of those shares
of Common Stock or the availability of those shares for sale will have on the market price of our Common Stock.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Substantial
future sales of shares of our Common Stock could cause the market price of our Common Stock to decline.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that significant additional capital will be needed in the near future to continue our planned operations. Sales of a substantial
number of shares of our Common Stock in the public market, or the perception that these sales might occur, could depress the market price
of our Common Stock and could impair our ability to raise capital through the sale of additional equity securities. We are unable to
predict the effect that such sales may have on the prevailing market price of our shares.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have financed our operations, and we expect to continue to finance our operations, acquisitions, if any, and the development of strategic
relationships by issuing equity, warrants and/or convertible securities, which could significantly reduce the percentage ownership of
our existing stockholders. Further, any additional financing that we secure may require the granting of rights, preferences or privileges
senior to, or <I>pari passu</I> with, those of Common Stock. Additionally, we may acquire other technologies or finance strategic alliances
by issuing our equity or equity-linked securities, which may result in additional dilution. Any issuances by us of equity securities
may be at or below the prevailing market price of our Common Stock and in any event may have a dilutive impact on your ownership interest,
which could cause the market price of our Common Stock to decline. We may also raise additional funds through the incurrence of debt
or the issuance or sale of other securities or instruments senior to our shares of Common Stock. The holders of any securities or instruments
we may issue may have rights superior to the rights of our holders of our Common Stock. If we experience dilution from issuance of additional
securities and we grant superior rights to new securities over common stockholders, it may negatively impact the trading price of our
shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
could issue &#8220;blank check&#8221; preferred stock without stockholder approval with the effect of diluting then current stockholder
interests and impairing their voting rights; and provisions in our charter documents could discourage a takeover that stockholders may
consider favorable.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
certificate of incorporation, as amended (the &#8220;Certificate of Incorporation&#8221;) authorizes the issuance of &#8220;blank check&#8221;
preferred stock with designations, rights and preferences as may be determined from time to time by our board of directors (the &#8220;Board&#8221;).
The Board is empowered, without stockholder approval, to issue a series of preferred stock with dividend, liquidation, conversion, voting
or other rights which could dilute the interest of, or impair the voting power of, our common stockholders. The issuance of a series
of preferred stock could be used as a method of discouraging, delaying or preventing a change in control. For example, it would be possible
for the Board to issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to change
control of our Company.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Series&#160;B Preferred Stock has a liquidation preference over our Common Stock.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this prospectus, we have 1,750 Series&#160;B Preferred Warrants outstanding, each exercisable for one share of Series&#160;B
Preferred Stock. The Series&#160;B Preferred Stock has a liquidation preference that gets paid prior to any payment on our Common Stock.
As a result, if we were to liquidate, dissolve or wind-up, each holder of our Series&#160;B Preferred Stock would have the right to receive
payment out of our assets available for distribution, before any amount is paid to the holders of our Common Stock, in an amount equal
in cash to 100% of the stated value of all shares of Series&#160;B Preferred Stock held by such holder, plus any other fees then due
and owing thereon, and no more, and if the assets of the Company shall be insufficient to pay in full such amounts, then the entire assets
to be distributed to the holders of Series&#160;B Preferred Stock shall be ratably distributed among such holders in accordance with
the respective amounts that would be payable on such shares if all amounts payable thereon were paid in full. The payment of the liquidation
preferences on the Series&#160;B Preferred Stock could result in holders of our Common Stock not receiving any proceeds if we were to
liquidate, dissolve or wind up, either voluntarily or involuntarily.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
existence of the liquidation preferences may reduce the value of our Common Stock, make it harder for us to sell shares of Common Stock
in offerings in the future, or prevent or delay a change of control.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
do not intend to pay dividends on shares of our Common Stock for the foreseeable future.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid any cash dividends on shares of our Common Stock and do not intend to pay any cash dividends in the foreseeable
future. We anticipate that we will retain all of our future earnings for use in the development of our business and for general corporate
purposes. Any determination to pay dividends in the future will be at the discretion of the Board. Accordingly, investors must rely on
sales of their Common Stock after price appreciation, which may never occur, as the only way to realize any future gains on their investments.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General
Risk Factors</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Economic
uncertainties or downturns, or political changes, in the United States and globally, could limit the availability of funds available
to our customers and potential customers, which could materially adversely affect our business.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
results of operations could be adversely affected by general conditions in the economy and financial markets, both in the U.S. and globally,
including conditions that are outside of our control, such as the continuing uncertainty regarding changes to tariffs and the duration
and scope of the COVID-19 pandemic, global supply chain disruptions, the recent inflation in the United States and the foreign and domestic
government sanctions imposed on Russia as a result of its recent invasion of Ukraine. There continues to be volatility and disruptions
in the capital and credit markets, and a severe or prolonged economic downturn, including, but not limited to as a result of such events,
could result in a variety of risks to our business, including weakened demand for our products and our ability to raise additional capital
when needed on acceptable terms, if at all. A weak or declining economy could strain our suppliers, possibly resulting in supply disruption,
or cause delays in payments for our services. In turn, we may be required to increase our allowance for doubtful accounts, which would
adversely affect our financial results. Any of the foregoing could harm our business and we cannot anticipate all the ways in which the
current economic climate and financial market conditions could adversely impact our business.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Changes
in government trade policies, including the imposition of tariffs and export restrictions, could have an adverse impact on our business
operations and sales.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
United States or foreign governments may enact changes in government trade policies that could adversely impact our ability to sell products
in certain countries, particularly in China. For example, the U.S. government has imposed tariffs on certain Chinese imports and, in
return, the Chinese government has imposed or proposed tariffs on certain U.S. products. Additionally, export restrictions imposed by
the U.S. government, including the addition of licensing requirements by the United States Department of Commerce&#8217;s Bureau of Industry
and Security (&#8220;BIS&#8221;), through the addition of companies to the BIS Entity List, may require us to suspend our business with
certain international customers if we conclude or are notified by the U.S. government that such business presents a risk of noncompliance
with U.S. regulations. We cannot predict what actions may ultimately be taken with respect to tariffs or trade relations between certain
countries, what products may be subject to such actions, or what actions may be taken by other countries in response. It also may not
be possible to anticipate the timing or duration of such tariffs, export restrictions, or other regulatory actions. These government
trade policies may materially adversely affect our sales and operations with current customers as well as impede our ability to develop
relationships with new customers.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is a risk of further escalation and retaliatory actions between the U.S. and other foreign governments. If significant tariffs or other
restrictions are placed on goods exported from China or any related counter-measures are taken, our revenue and results of operations
may be materially harmed. These tariffs may also make our customers&#8217; products more expensive for consumers, which may reduce consumer
demand.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is also a risk that the U.S. government may seek to implement more protective trade measures, not just with respect to China but with
respect to other countries as well, such as those imposed on Russia in connection with its recent invasion of Ukraine. This could include
new or higher tariffs and even more restrictive trade barriers, such as prohibiting certain types of, or all sales of certain products
or products sold by certain parties into the U.S. Any increased trade barriers or restrictions on global trade could have a materially
adverse impact on our business and financial results.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>A
decline in discretionary consumer spending may adversely affect our industry, our operations and ultimately our profitability.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Luxury
products, such as speaker systems, TVs, game consoles and PCs, are discretionary purchases for consumers. Any reduction in consumer discretionary
spending or disposable income may affect our industry significantly. Many economic factors outside of our control could affect consumer
discretionary spending, including the financial markets, consumer credit availability, prevailing interest rates, energy costs, employment
levels, salary levels, and tax rates. Any reduction in discretionary consumer spending could materially adversely affect our business
and financial condition.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Consumer
spending weakness could impact our revenue.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weakness
in general economic conditions may suppress consumer demand in our markets. Many of the products in which our technologies are incorporated
are discretionary goods, such as home-theater systems. Weakness in general economic conditions may also lead to customers becoming delinquent
on their obligations to us or being unable to pay, resulting in a higher level of write-offs. Economic conditions may impact the amount
businesses spend on their speaker systems. Weakness in economic conditions could lessen demand for our products and negatively affect
our revenue.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 22; Options: NewSection; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we are unable to attract, integrate and retain additional qualified personnel, including top technical talent, our business could be
adversely affected.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future success depends in part on our ability to identify, attract, integrate and retain highly skilled technical, managerial, sales
and other personnel. We face intense competition for qualified individuals from numerous other companies, including other software and
technology companies, many of whom have greater financial and other resources than we do. Some of these characteristics may be more appealing
to high-quality candidates than those we have to offer. In addition, new hires often require significant training and, in many cases,
take significant time before they achieve full productivity. We may incur significant costs to attract and retain qualified personnel,
including significant expenditures related to salaries and benefits and compensation expenses related to equity awards, and we may lose
new employees to our competitors or other companies before we realize the benefit of our investment in recruiting and training them.
Moreover, new employees may not be or become as productive as we expect, as we may face challenges in adequately or appropriately integrating
them into our workforce and culture. If we are unable to attract, integrate and retain suitably qualified individuals who are capable
of meeting our growing technical, operational and managerial requirements, on a timely basis or at all, our business will be adversely
affected.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility
or lack of positive performance in our share price may also affect our ability to attract and retain our key employees. Many of our senior
management personnel and other key employees have become, or will soon become, vested in a substantial amount of shares of Common Stock,
restricted stock units or warrants to purchase Common Stock. Employees may be more likely to leave us if the shares they own or the shares
underlying their vested units or warrants have significantly appreciated in value relative to the original grant prices of the shares
or units or the exercise prices of the warrants, or, conversely, if the exercise prices of the warrants that they hold are significantly
above the market price of our Common Stock. If we are unable to appropriately incentivize and retain our employees through equity compensation,
or if we need to increase our compensation expenses in order to appropriately incentivize and retain our employees, our business, operating
results and financial condition would be adversely affected.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may be subject to litigation for a variety of claims, which could adversely affect our results of operations, harm our reputation or
otherwise negatively impact our business.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be subject to litigation for a variety of claims arising from our normal business activities. These may include claims, suits, and
proceedings involving labor and employment, wage and hour, commercial and other matters. The outcome of any litigation, regardless of
its merits, is inherently uncertain. Any claims and lawsuits, and the disposition of such claims and lawsuits, could be time-consuming
and expensive to resolve, divert management attention and resources, and lead to attempts on the part of other parties to pursue similar
claims. Any adverse determination related to litigation could adversely affect our results of operations, harm our reputation or otherwise
negatively impact our business. In addition, depending on the nature and timing of any such dispute, a resolution of a legal matter could
materially affect our future operating results, our cash flows or both.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
requirements of being a U.S. public company may strain our resources and divert management&#8217;s attention.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a U.S. public company, we are subject to the reporting requirements of the Exchange Act, the Sarbanes-Oxley Act, the Dodd-Frank Act,
the listing requirements of Nasdaq, and other applicable securities rules&#160;and regulations.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance
with these rules&#160;and regulations increases our legal and financial compliance costs, makes some activities more difficult, time-consuming,
or costly, and increases demand on our systems and resources. The Exchange Act requires, among other things, that we file annual and
current reports with respect to our business and operating results.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
securities or industry analysts do not publish research or reports about our business, or publish negative reports about our business,
our Common Stock price and trading volume could decline.</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading market for our Common Stock may depend in part on the research and reports that securities or industry analysts may publish about
us or our business, our market and our competitors. We do not have any control over such analysts. If one or more such analysts downgrade
or publish a negative opinion of our Common Stock, the price of our shares would likely decline. If analysts do not cover us or do not
regularly publish reports on us, we may not be able to attain visibility in the financial markets, which could have a negative impact
on our share price or trading volume.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 23; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="km_002"></A>THE
SEPTEMBER 2024 TRANSACTION</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September&#160;10, 2024, the Company entered into the Exchange Agreements with certain holders of common stock purchase warrants exercisable
for an aggregate of up to 5,135,182 shares of Common Stock originally issued on February&#160;13, 2024 and having a then current exercise
price of $1.83 (such warrants, the &#8220;February&#160;2024 Warrants&#8221;). The February&#160;2024 Warrants and the shares of Common
Stock underlying the February&#160;2024 Warrants were registered on the Company&#8217;s registration statement on Form&#160;S-1 (File
No.&#160;333-276631). Pursuant to the Exchange Agreements, the Holders agreed to exchange their February&#160;2024 Warrants for newly
issued common stock purchase warrants (the &#8220;Exchange Warrants&#8221;) exercisable for an aggregate of up to 5,135,182 shares of
Common Stock, at an exercise price of $2.21 per share. The Exchange Warrants were issued pursuant to an exemption from the registration
requirements of the Securities Act contained in Section&#160;3(a)(9)&#160;thereof. As of the date of this prospectus, Exchange Warrants
exercisable for 2,228,628 shares of Common Stock have been exercised, and the remaining Exchange Warrants are the September&#160;2024
Warrants.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="km_003"></A>THE
FEBRUARY 2025 TRANSACTION</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February&#160;14, 2025, the Company closed an offering (the &#8220;February&#160;2025 Offering&#8221;) pursuant to that certain securities
purchase agreement (the &#8220;February&#160;2025 Purchase Agreement&#8221;) with the investors party thereto (the &#8220;February&#160;2025
Investors&#8221;). In the February&#160;2025 Offering, the Company issued and sold to the February&#160;2025 Investors in a registered
direct offering, (a)&#160;an aggregate of 4,757,126 shares of Common Stock, and (b)&#160;common stock purchase warrants exercisable for
an aggregate of up to 4,757,126 shares of Common Stock, at an exercise price of $1.14 per share at a combined offering price of $1.14
per share of Common Stock and accompanying warrant, for aggregate gross proceeds of approximately $5.4 million.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the February&#160;2025 Offering, on February&#160;13, 2025, the Company entered into a placement agency agreement (the
 &#8220;February&#160;2025 Placement Agency Agreement&#8221;) with the Placement Agent, pursuant to which the Placement Agent agreed to
act as placement agent on a &#8220;reasonable best efforts&#8221; basis in connection with the February&#160;2025 Offering. Pursuant
to the February&#160;2025 Placement Agency Agreement, the Company agreed to pay the Placement Agent an aggregate fee equal to 7.0% of
the gross proceeds raised in the February&#160;2025 Offering and reimburse the Placement Agent an amount up to $75,000 for expenses in
connection with the February&#160;2025 Offering. The Company also issued to an affiliate of the Placement Agent the Placement Agent Warrants
to purchase up an aggregate of 475,713 shares of Common Stock, which is equal to 5.0% of the aggregate number of securities sold in the
February&#160;2025 Offering, at an exercise price equal to 125.0% of the offering price per share of Common Stock and accompanying Warrant
in the February&#160;2025 Offering, or $1.425 per share.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Placement Agent Warrants are exercisable on or after August&#160;14, 2025 and will expire on the five year anniversary of such date.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 24; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="km_004"></A>THE
APRIL 2025 TRANSACTION</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March&#160;31, 2025, the Company entered into the Purchase Agreement with the holders of the 2025 Investor Warrants, pursuant to which
such holders agreed to purchase from the Company (a)&#160;in a registered direct offering, senior secured convertible notes having an
aggregate principal amount of $5,555,555 (the &#8220;Initial Notes&#8221;) for an aggregate purchase price of $5,000,000 and senior secured
convertible notes having an aggregate principal amount of $11,111,111 (the &#8220;Additional Notes&#8221;, and together with the Initial
Notes, the &#8220;Notes&#8221;) for an aggregate purchase price of $10,000,000 upon satisfaction of certain closing conditions applicable
to the Initial Notes and Additional Notes, respectively and (b)&#160;in a concurrent private placement, 2025 Investor Warrants to purchase
up to 19,346,101 shares of Common Stock of the Company, of which 2025 Investor Warrants to purchase up to 6,448,700 shares (the &#8220;Initial
Warrant Shares&#8221;) of Common Stock were required to be issued in connection with the issuance of the Initial Notes (the &#8220;Initial
Warrants&#8221;) and 2025 Investor Warrants to purchase up to 12,897,401 shares (the &#8220;Additional Warrant Shares&#8221;) of Common
Stock were required to be issued in connection with the issuance of the Additional Notes (the &#8220;Additional Warrants&#8221;).</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing of Initial Notes and Initial Warrants (the &#8220;Initial Closing&#8221;) took place on April&#160;3, 2025. The closing of the
Additional Notes and Additional Warrants (the &#8220;Additional Closing,&#8221; and together with the Initial Closing, the &#8220;Closings&#8221;)
was required to take place on or after the date that is 20 days after the mailing by the Company of a definitive information statement
on Schedule 14(c)&#160;(the &#8220;Information Statement&#8221;) with respect to the approval, by written consent of the Company&#8217;s
stockholders, of the issuance of the shares of Common Stock issuable upon conversion of the Notes and exercise of the 2025 Investor Warrants
and a one-time reset, at the Company&#8217;s option, of the exercise price of outstanding common stock purchase warrants issued to holders
of the 2025 Investor Warrants prior to the Initial Closing that do not contain &#8220;alternative cashless exercise&#8221; features (the
 &#8220;Stockholder Approval&#8221;). The Information Statement was mailed on April&#160;28, 2025, and the Additional Closing occurred
on May&#160;19, 2025.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Purchase Agreement, the Company agreed,&#160;subject to certain exceptions, (i)&#160;not to offer for sale, issue, sell, contract
to sell, pledge or otherwise dispose of any of shares of Common Stock or securities convertible into shares of Common Stock until 45
days after the date of each Closing, and (ii)&#160;not to issue certain securities if the issuance would constitute a Variable Rate Transaction
(as such term is defined in the Purchase Agreement) until no April&#160;2025 Purchaser holds any Notes.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Purchase Agreement, until the date that is 18 months after the date on which the Notes are no longer outstanding, the April&#160;2025
Purchasers have the right, but not the obligation, to participate in any issuance by the Company of any debt, preferred stock, shares
of Common Stock or securities convertible into shares of Common Stock (a &#8220;Subsequent Financing&#8221;) up to a maximum of 65% of
such Subsequent Financing on the same terms, conditions and price provided to other investors in such Subsequent Financing.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Warrants</I></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants have an initial exercise price of $0.8615 per share. The Initial Warrants will be exercisable upon effectiveness of Stockholder
Approval and expire five (5)&#160;years from the date of such effectiveness. The Additional Warrants were issued in the Additional Closing,
exercisable immediately upon issuance and expire five (5)&#160;years from the date of issuance. The exercise price of the Warrants is
subject to (a)&#160;downward adjustment in the event the Company issues shares of common stock or common stock equivalents having an
effective price lower than the then current exercise price of the Warrants, subject to certain exceptions and (b)&#160;standard, proportional
adjustments upon the occurrence of certain events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers
or other corporate changes.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants contain 4.99/9.99% beneficial ownership limitations.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Notes</I></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notes carry a 10% original issue discount, and mature 18 months from the date of issuance. No interest accrues during the term of the
Notes, unless an event of default occurs, in which case interest will accrue at a rate of 12% per annum. The obligations under the Notes
rank senior to all other existing indebtedness and equity of the Company. The Notes are convertible into shares of Common Stock at any
time beginning on the date of Stockholder Approval at the option of the holders thereof, in whole or in part, into such number of shares
of Common Stock at an initial conversion price equal to $1.00 per share (the &#8220;Conversion Price&#8221;). Alternatively, the Notes
are convertible at a price (the &#8220;Alternate Conversion Price&#8221;) equal to the greater of (x)&#160;the Floor Price (as defined
below) and (y)&#160;90% of the lowest volume weighted adjusted price of the shares of Common Stock (the &#8220;VWAP&#8221;) in the ten
(10)&#160;trading days prior to the applicable conversion date (&#8220;Alternate Conversions&#8221;).</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
conversion price of the Notes is subject to a floor price of $0.1794 (the &#8220;Floor Price&#8221;).</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 25; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event the Alternate Conversion Price would be lower than the Floor Price, the Company is required to compensate the holders of the
Notes by paying the holders in cash an amount (the &#8220;Alternate Conversion Floor Amount&#8221;) equal to the product obtained by
multiplying (A)&#160;the VWAP on the day the holder delivers the applicable conversion notice and (B)&#160;the difference obtained by
subtracting (I)&#160;the number of shares of Common Stock delivered (or to be delivered) to the holder on the applicable share delivery
date with respect to such Alternate Conversion from (II)&#160;the quotient obtained by dividing (x)&#160;the applicable conversion amount
that the holder has elected to be the subject of the applicable Alternate Conversion, by (y)&#160;the applicable Alternate Conversion
Price without being limited by the Floor Price.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Notes, the Company is required to use up to 30% of the proceeds from future financings to redeem the Notes in an amount equal to
the aggregate principal amount of the Notes being redeemed from such proceeds multiplied by 105%.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notes contain 4.99/9.99% beneficial ownership limitations and customary provisions regarding events of defaults and negative covenants.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 26; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="km_005"></A>SELLING
STOCKHOLDERS</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares being offered by the Selling Stockholders are the September&#160;2024 Warrant Shares, the Placement Agent Warrant Shares
and the 2025 Investor Warrant Shares issuable upon the exercise of the September&#160;2024 Warrants, the Placement Agent Warrants and
the 2025 Investor Warrants, respectively. For additional information regarding the issuance of the September&#160;2024 Warrants, see
 &#8220;The September&#160;2024 Transaction&#8221; on page&#160;22. For additional information regarding the issuance of the Placement
Agent Warrants, see &#8220;The February&#160;2025 Transaction&#8221; on page&#160;22. For additional information regarding the issuance
of the 2025 Investor Warrants, see &#8220;The April&#160;2025 Transaction&#8221; on page&#160;23.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are registering the Warrant Shares to permit the Selling Stockholders to offer such shares for resale from time to time. Except for the
ownership of the September&#160;2024 Warrants, the Placement Agent Warrants and the 2025 Investor Warrants and as disclosed in this section
under &#8220;Material Relationships with Selling Stockholders&#8221; below, none of the Selling Stockholders have had any material relationship
with us within the past three (3)&#160;years.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information with respect to each Selling Stockholder, including (i)&#160;the shares of Common Stock
beneficially owned by the Selling Stockholder prior to this offering, (ii)&#160;the number of Shares being offered by the Selling Stockholder
pursuant to this prospectus and (iii)&#160;the Selling Stockholder&#8217;s beneficial ownership after completion of this offering. The
registration of the Warrant Shares issuable to the Selling Stockholders upon the exercise of the Warrants does not necessarily mean that
the Selling Stockholders will sell all or any of such shares, but the number of shares of Common Stock and percentages set forth in the
final two columns below assume that all Warrant Shares are issued to, and sold by, the Selling Stockholders. The final two columns also
assume the exercise of all of the Warrants held by the Selling Stockholders as of July&#160;2, 2025, and take into account the effect
of the Beneficial Ownership Limitations (as defined below) in any warrants held by the holders of the Warrants (the &#8220;Warrant Holders&#8221;)
after this offering. See &#8220;Plan of Distribution&#8221;.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table is based on information supplied to us by the Selling Stockholders, with beneficial ownership and percentage ownership determined
in accordance with the rules&#160;and regulations of the SEC, and includes voting or investment power with respect to shares of Common
Stock. This information does not necessarily indicate beneficial ownership for any other purpose.&#8239;In computing the number of shares
of Common Stock beneficially owned by a Selling Stockholder and the percentage ownership of such Selling Stockholder, shares of Common
Stock subject to securities held by that Selling Stockholder that are exercisable for or convertible into shares of Common Stock within
60 days after July&#160;2, 2025 are deemed outstanding. Such shares of Common Stock, however, are not deemed outstanding for the purposes
of computing the percentage ownership of any other Selling Stockholder.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 12pt">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Number of<BR>Shares <BR>Beneficially<BR>Owned<BR>Prior to<BR>Offering</TD>
    <TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Maximum<BR>Number of<BR>Shares<BR>to be Sold<BR>Pursuant to<BR>this<BR>Prospectus</TD>
    <TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number of<BR>Shares <BR>Beneficially<BR>Owned<BR>After<BR>Offering<SUP>(3)</SUP></B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percentage<BR>Beneficially<BR>Owned<BR>After<BR>Offering<SUP>(3)</SUP></B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 44%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anson East Master Fund LP<SUP>(4)</SUP>&#160;</FONT></TD>
    <TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">3,786,224</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><SUP>(1)(7)</SUP>&nbsp;</TD>
    <TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">3,786,224</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><SUP>(2)</SUP>&nbsp;</TD>
    <TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">&ndash;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">&ndash;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anson Investments Master Fund LP<SUP>(4)</SUP>&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">9,396,472</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><SUP>(1)(8)</SUP>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">13,597,211</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><SUP>(2)</SUP>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&ndash;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&ndash;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gregory Castaldo<SUP>(5)</SUP>&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,000,000</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><SUP>(1)(9)</SUP>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,000,000</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><SUP>(2)</SUP>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&ndash;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&ndash;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph Reda<SUP>(6)</SUP>&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,869,220</TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><SUP>(1)(10)</SUP>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,869,220</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><SUP>(2)</SUP>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&ndash;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&ndash;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maxim Partners, LLC<SUP>(11)</SUP>&#160;&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">475,713</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">475,713</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><SUP>(2)</SUP>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&ndash;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&ndash;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  </TABLE>



<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 12pt">
  <TR>
    <TD STYLE="width: 6%; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)&#160;</FONT></TD>
    <TD STYLE="width: 94%; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All of the
    Warrants contain certain beneficial ownership limitations, which provide that a holder of the Warrants may not exercise any portion
    of its Warrants if such holder, together with its affiliates, would beneficially own in excess of 9.99% (or in the case of the Placement
    Agent Warrants, 4.99%) of the number of shares of Common Stock outstanding immediately after giving effect to such exercise (each
    such limitation, a &#8220;Beneficial Ownership Limitation&#8221;). As a result, the number of shares of Common Stock reflected as
    beneficially owned by each Warrant Holder includes (i)&#160;any outstanding shares of Common Stock held by such Selling Stockholder
    and (ii)&#160;if any, the number of Warrant Shares offered hereby and any other securities convertible into and exercisable for shares
    of Common Stock that may be held by such Selling Stockholder, in each case which such Warrant Holder has the right to acquire as
    of July&#160;2, 2025 and without it or any of its affiliates beneficially owning more than 9.99%, as applicable, of the number of
    outstanding shares of Common Stock as of July&#160;2, 2025.&#160;&#160;&#160; </FONT></TD></TR>

<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&#160;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 94%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    shares of Common Stock issuable to the Warrant Holders upon full exercise of the Warrants, without giving effect to the Beneficial
    Ownership Limitations.</FONT></TD></TR>
</TABLE>
<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 27; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 12pt">
  <TR>
    <TD STYLE="vertical-align: top; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="vertical-align: top; width: 94%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The number of shares owned and the percentage of beneficial ownership after this offering set forth in these columns are based on 107,390,677 shares of Common Stock outstanding, which includes 84,662,309 shares of Common Stock outstanding as of July&#160;2, 2025 and assumes full exercise of the Warrants that are exercisable for the 22,728,368 Warrant Shares offered hereby. The calculation of beneficial ownership reported in such columns takes into account the effect of the Beneficial Ownership Limitations in any Warrants held by the Selling Stockholders after this offering. &#160; </FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anson Advisors Inc and Anson Funds Management LP, the Co-Investment Advisers of Anson Investments Master Fund LP (&#8220;AIMF&#8221;) and Anson East Master Fund LP (&#8220;AEMF&#8221;, and collective with AIMF, &#8220;ANSON&#8221;), hold voting and dispositive power over the shares of Common Stock held by ANSON. Tony Moore is the managing member of Anson Management GP LLC, which is the general partner of Anson Funds Management LP. Moez Kassam and Amin Nathoo are directors of Anson Advisors Inc. Mr.&#160;Moore, Mr.&#160;Kassam and Mr.&#160;Nathoo each disclaim beneficial ownership of these shares of Common Stock except to the extent of their pecuniary interest therein. The principal business address of ANSON is Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands.</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gregory Castaldo is a United States citizen with a principal residence at 3776 Steven James Drive, Garnet Valley, Pennsylvania 19060.&#160;&#160;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph Reda is United States citizen with a principal business address of 1 Wolfs Lane, Suite&#160;316, Pelham, NY 10803.</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These shares consist of (a)&#160;381,310 September&#160;2024 Warrant Shares, (b)&#160;1,134,971 Initial Warrant Shares and (c)&#160;2,269,943 Additional Warrant Shares. </FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These shares consist of (a)&#160;1,525,244 September&#160;2024 Warrant Shares, (b)&#160;4,023,989 Initial Warrant Shares and (c)&#160;8,047,978 Additional Warrant Shares, adjusted to reflect the 9.99% Beneficial Ownership Limitation applicable to such Selling Stockholder. </FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These shares consist of 1,000,000 September&#160;2024 Warrant Shares.&#160;&#160;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)&#160;&#160;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These shares are held by SEC Opportunity Fund, LLC and consist of (a)&#160;1,289,740 Initial Warrant Shares and (b)&#160;2,579,480 Additional Warrant Shares.&#160;&#160;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The address of Maxim Partners, LLC is c/o Maxim Group LLC, 300 Park Avenue, 16th Floor, New York, NY 10022. MJR Holdings LLC (&#8220;MJR&#8221;) is the managing member of Maxim Partners, LLC. Cliff Teller is the Chief Executive Officer of MJR and has dispositive power over the securities held by Maxim Partners, LLC. Mr.&#160;Teller disclaims beneficial ownership over any securities owned by Maxim Partners, LLC and MJR except to the extent of his pecuniary interest therein.</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Material
Relationships with Selling Stockholders</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>February&#160;2023
Registered Direct Offering and Concurrent Private Placement</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January&#160;31, 2023, we entered into a securities purchase agreement (the &#8220;February&#160;2023 Purchase Agreement&#8221;) with
certain investors, including the Warrant Holders other than Maxim Partners, LLC (such holders, the &#8220;Investor Warrant Holders&#8221;).
Under the February&#160;2023 Purchase Agreement, we agreed to issue and sell to such Investor Warrant Holders (i)&#160;in a registered
direct offering, 1,344 shares of Common Stock and pre-funded warrants to purchase up to 2,545 shares of Common Stock, and (ii)&#160;in
a concurrent private placement, warrants exercisable for an aggregate of up to 5,833 shares of Common Stock, at an exercise price of
$1,573.50 per share of Common Stock (the &#8220;February&#160;2023 Warrants&#8221;). The offering closed on February&#160;3, 2023 and
we received gross proceeds of approximately $6.2 million before deducting fees and other offering expenses payable by us.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>March&#160;2023
Registered Direct Offering and Concurrent Private Placement</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March&#160;27, 2023, we entered into a securities purchase agreement (the &#8220;March&#160;2023 Purchase Agreement&#8221;) with certain
investors, including the Investor Warrant Holders. Under the March&#160;2023 Purchase Agreement, we agreed to issue and sell to such
investors (i)&#160;in a registered direct offering, 5,581 shares of Common Stock and (ii)&#160;in a concurrent private placement, warrants
exercisable for an aggregate of up to 11,163 shares of Common Stock, at an exercise price of $286.50 per share of Common Stock (the &#8220;March&#160;2023
Warrants&#8221;). The offering closed on March&#160;29, 2023 and we received gross proceeds of approximately $1.8 million before deducting
fees and other offering expenses payable by us.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>April&#160;2023
Registered Direct Offering and Concurrent Private Placement</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April&#160;7, 2023, we entered into a securities purchase agreement (the &#8220;April&#160;2023 Purchase Agreement&#8221;) with certain
investors, including the Investor Warrant Holders. Under the April&#160;2023 Purchase Agreement, we agreed to issue and sell to such
investors (i)&#160;in a registered direct offering, 4,954 shares of Common Stock and (ii)&#160;in a concurrent private placement, warrants
exercisable for an aggregate of up to 9,908 shares of Common Stock, at an exercise price of $211.50 per share of Common Stock (the &#8220;April&#160;2023
Warrants&#8221;). The offering closed on April&#160;12, 2023 and we received gross proceeds of approximately $1.2 million before deducting
fees and other offering expenses payable by us.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 28; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>May&#160;2023
Warrant Inducement</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May&#160;15, 2023, we entered into warrant exercise inducement offer letters with holders of the April&#160;2023 Warrants, including
the Investor Warrant Holders, pursuant to which the holders agreed to exercise for cash, certain of the April&#160;2023 Warrants in exchange
for the Company&#8217;s agreement to issue the new common stock purchase warrants (the &#8220;May&#160;2023 Inducement Warrants&#8221;).
The Company received aggregate gross proceeds of approximately $2.1 million from the exercise of the April&#160;2023 Warrants by the
holders before deducting fees and other offering expenses payable by us.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
May&#160;2023 Inducement Warrant is exercisable at a price per share of Common Stock of $199.50, was immediately exercisable upon issuance
and will expire on the fifth anniversary of its issuance. The exercise price of the May&#160;2023 Inducement Warrants is subject to appropriate
adjustment in the event of recapitalization events, stock dividends, stock splits, stock combinations, reclassifications, reorganizations
or similar events affecting the Company&#8217;s Common Stock. The Company and Investor Warrant Holders have agreed that the May&#160;2023
Inducement Warrants are callable by the Company at a redemption price of $75.00 per May&#160;Inducement 2023 Warrant, provided that the
resale of the shares of Common Stock underlying the May&#160;Inducement Warrants are then registered or may be resold under Rule&#160;144
under the Securities Act.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of Common Stock issuable upon exercise of the May&#160;2023 Inducement Warrants have been registered for resale pursuant to a
Registration Statement on Form&#160;S-1 (File No.333-272278), which was declared effective by the SEC on June&#160;7, 2023.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>July&#160;2023
Warrant Inducement</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July&#160;26, 2023, we entered into warrant exercise inducement offer letters with holders of the March&#160;2023 Warrants and May&#160;2023
Inducement Warrants, including the Investor Warrant Holders, pursuant to which the holders agreed to exercise for cash, certain of the
March&#160;2023 Warrants and May&#160;2023 Inducement Warrants in exchange for the Company&#8217;s agreement to issue the new common
stock purchase warrants (the &#8220;July&#160;2023 Inducement Warrants&#8221;). The Company received aggregate gross proceeds of approximately
$678,000 from the exercise of certain of the May&#160;2023 Inducement Warrants by the holders before deducting fees and other offering
expenses payable by us.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
July&#160;2023 Inducement Warrant is exercisable at a price per share of Common Stock of $193.50, was immediately exercisable upon issuance
and will expire on the fifth anniversary of its issuance. The exercise price of the July&#160;2023 Inducement Warrants is subject to
appropriate adjustment in the event of recapitalization events, stock dividends, stock splits, stock combinations, reclassifications,
reorganizations or similar events affecting the Company&#8217;s Common Stock. The Company and the Investor Warrant Holders have agreed
that the July&#160;2023 Inducement Warrants are callable by the Company at a redemption price of $75.00 per July&#160;2023 Inducement
Warrant, provided that the resale of the shares of Common Stock underlying such warrants are then registered or may be resold under Rule&#160;144
under the Securities Act.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of Common Stock issuable upon exercise of the July&#160;2023 Inducement Warrants have been registered for resale pursuant to a
Registration Statement on Form&#160;S-1 (File No.&#160;333-274155), which was declared effective by the SEC on August&#160;30, 2023.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>September&#160;2023
Waiver Agreement</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September&#160;1, 2023, we entered into a waiver agreement (the &#8220;Waiver Agreement&#8221;) with certain purchasers who executed
the March&#160;2023 Purchase Agreement and April&#160;2023 Purchase Agreement, including the Investor Warrant Holders, whereby the purchasers
agreed to waive the prohibition on Variable Rate Transactions (as defined in each of the March&#160;2023 Purchase Agreement and the April&#160;2023
Purchase Agreement). In consideration therefor, we granted to the purchasers the right to participate in any subsequent financings of
the Company occurring on or prior to September&#160;1, 2024, up to an amount equal to 90%, in aggregate, of the total dollar value raised
in any such financing, on the same terms and conditions provided to other investors. Such right of participation was terminated and superseded
by the right of participation granted to the Investor Warrant Holders pursuant to the March&#160;2024 Purchase Agreement, as further
described below.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: White"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>October&#160;2023
Public Offering</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October&#160;16, 2023, we entered into a securities purchase agreement (the &#8220;October&#160;2023 Purchase Agreement&#8221;) with
certain investors, including the Investor Warrant Holders. Under the October&#160;2023 Purchase Agreement, we issued and sold to such
investors in a public offering (the &#8220;October&#160;2023 Public Offering&#8221;) (i)&#160;87,000 units, with each unit consisting
of (A)&#160;one (1)&#160;share of Series&#160;B Preferred Stock, and (B)&#160;two Preferred Warrants, with each Preferred Warrant exercisable
for Preferred Warrant Share, at the public offering price of $55.00 per unit.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 29; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
October&#160;2023 Public Offering closed on October&#160;17, 2023, and we received gross proceeds of approximately $4.5 million before
deducting fees and other offering expenses payable by us.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>December&#160;2023
Warrant Inducement</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December&#160;5, 2023, we entered into warrant inducement letter agreements (the &#8220;December&#160;2023 Inducement Agreements&#8221;)
with certain holders of the Series&#160;B Preferred Warrants exercisable for up to 168,972 shares of Series&#160;B Preferred Stock, issued
pursuant to the Series&#160;B Preferred Stock Offering (the &#8220;Existing Preferred Warrants&#8221;). Pursuant to the December&#160;2023
Inducement Agreements, the holders of the Existing Preferred Warrants agreed to a reduced exercise price of $35.72 per share of Series&#160;B
Preferred Stock, while maintaining the original fixed conversion price of $62.205 (the &#8220;Conversion Price&#8221;) of the Series&#160;B
Preferred Stock, upon the exercise of any Existing Preferred Warrants during the period (the &#8220;December&#160;2023 Inducement Period&#8221;)
commencing from the date of the Inducement Agreements until the later of (i)&#160;the day immediately preceding the date stockholder
approval for the issuance of shares of Common Stock underlying the New Inducement Warrants (defined below) pursuant to the Nasdaq Requirement
is obtained (the &#8220;Warrant Inducement Stockholder Approval Date&#8221;), or (ii)&#160;January&#160;15, 2024. As of February&#160;13,
2024, the Inducement Period has ended as all outstanding shares of Series&#160;B Preferred Stock held by the holders of Existing Preferred
Warrants have been repurchased and all outstanding Existing Preferred Warrants have been cancelled pursuant to the February&#160;2024
Side Letters (as defined below). As of February&#160;13, 2024, the holders of the Existing Preferred Warrants have exercised such warrants
to purchase 87,657 shares of Series&#160;B Preferred Stock, and we have received approximately $3.1 million in gross proceeds from such
exercises (the &#8220;December&#160;2023 Warrant Inducement Transaction&#8221;).</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the December&#160;2023 Inducement Agreements, we issued common stock purchase warrants (the &#8220;New Inducement Warrants&#8221;)
to purchase up to 281,828 shares of Common Stock to the holders of the Existing Preferred Warrants. The New Inducement Warrants have
an initial exercise price of $22.23 per share, contain 4.99/9.99% beneficial ownership limitations, are not exercisable until after the
Warrant Inducement Stockholder Approval Date and expire five years from the Warrant Inducement Stockholder Approval Date. The exercise
price of the New Inducement Warrants is subject to downward adjustment upon any subsequent transaction at a price lower than the exercise
price then in effect. Following the March&#160;2024 Registered Direct Offering and Concurrent Private Placement (as defined below), the
exercise price of the New Inducement Warrants was downward adjusted to $4.50 per share. Following our reverse stock split effective April&#160;12,
2024 (the &#8220;Reverse Stock Split&#8221;), the New Inducement Warrants are immediately exercisable.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise price and the number of shares of Common Stock issuable upon exercise of each New Inducement Warrant are subject to appropriate
adjustments in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications or similar
events affecting the common stock. Pursuant to a one-time reset right under the terms of such warrants, the exercise price of such warrants
was reset at $1.8302 as a result of the Reverse Stock Split, and all such warrants were exercised for cash at such price shortly after
the price reset became effective.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the December&#160;2023 Inducement Agreements, we agreed to (a)&#160;file a registration statement to register the resale of the shares
of Common Stock underlying the New Inducement Warrants as soon as reasonably practicable, but in any event no later than 45 calendar
days following the Warrant Inducement Stockholder Approval Date, and to use commercially reasonable efforts to have such resale registration
statement declared effective by the SEC as soon as practicable and to keep such registration statement effective at all times until no
such holder owns any such New Inducement Warrants or shares of Common Stock issuable upon exercise thereof, and (b)&#160;hold an annual
or special meeting of stockholders on or prior to the date that is ninety (90) days (which was subsequently extended to one hundred and
five (105) days) following the date of the December&#160;2023 Inducement Agreements for the purpose of obtaining stockholder approval
of such transaction. A registration statement on Form&#160;S-3 (file No.&#160;333-278622) was filed with the SEC on April&#160;11, 2024
to register the shares of Common Stock underlying the New Inducement Warrants and the 2024 Bridge Warrant Shares (as defined below),
and such registration statement was declared effective on April&#160;18, 2024.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
engaged Maxim Group LLC (&#8220;Maxim&#8221;) as exclusive financial advisor to provide financial services in connection with the transactions
summarized above and, pursuant to a certain financial advisory agreement, dated December&#160;5, 2023, by and between the Company and
Maxim, agreed to pay Maxim a cash financial advisory fee equal to 8% of the aggregate gross proceeds received from the exercise of Existing
Preferred Warrants by the holders thereof. In addition, we agreed to reimburse Maxim for its accountable legal expenses in connection
with the exercise of the Existing Preferred Warrants and the issuance of the New Inducement Warrants of up to $10,000.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February&#160;5, 2024, we and the holders of the New Inducement Warrants entered into a warrant amendment agreement, pursuant to which
the date we are first required to reserve shares of Common Stock underlying the New Inducement Warrants was postponed from the date of
the New Inducement Warrants were issued to the Warrant Inducement Stockholder Approval Date.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 30; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
January&#160;1, 2024 through June&#160;10, 2024, (a)&#160;the holders of the Existing Preferred Warrants have exercised such warrants
to purchase 29,322 shares of Series&#160;B Preferred Stock, and we have received approximately $714,000 in gross proceeds from such exercises,
and (b)&#160;we issued New Inducement Warrants to purchase up to 94,275 shares of Common Stock to the holders of the Existing Preferred
Warrants.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>2024
Bridge Note and Warrant</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January&#160;22, 2024, we entered into securities purchase agreements (the &#8220;2024 Bridge Purchase Agreements&#8221;), with the holders
of Series&#160;B Preferred Warrants, pursuant to which we agreed to issue to such holders promissory notes in the aggregate principal
amount of $1,000,000 (the &#8220;2024 Bridge Promissory Notes&#8221;) and common stock purchase warrants (the &#8220;2024 Bridge Warrants&#8221;)
to purchase up to an aggregate of 66,665 shares of our Common Stock (&#8220;2024 Bridge Warrant Shares&#8221;), at an initial exercise
price of $22.23 per share, in consideration for $600,000 (the &#8220;2024 Bridge Private Placement&#8221;).</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the 2024 Bridge Promissory Notes matures on the earlier to occur of: (i)&#160;July&#160;17, 2024, and (ii)&#160;the full or partial
exercise of certain Series&#160;B Preferred Warrants then held by the applicable holder, issuable for at least 9,322 shares of the Series&#160;B
Preferred Stock upon such full or partial exercise. The 2024 Bridge Promissory Notes do not bear interest except upon the occurrence
of an event of default. The 2024 Bridge Promissory Notes are not convertible into shares of Common Stock or Series&#160;B Preferred Stock.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
any time after issuance of the 2024 Bridge Promissory Notes, we may repay all or less than all of the outstanding principal amount of
the 2024 Bridge Promissory Notes, with no penalty or premium of any kind, upon at least one day&#8217;s written notice to the applicable
holder of such notes.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2024 Bridge Warrants contain 4.99/9.99% beneficial ownership limitations and are not exercisable until after the date that stockholder
approval is obtained to approve each of (i)&#160;the issuance of the 2024 Bridge Warrant Shares issuable upon the exercise of the 2024
Bridge Warrants, as may be required by the applicable rules&#160;and regulations of Nasdaq and (ii)&#160;if necessary, a proposal to
amend the our Certificate of Incorporation to increase the authorized share capital of the Company to an amount sufficient to cover the
2024 Bridge Warrant Shares or to effectuate a reverse stock split whereby the authorized share capital is not split and is sufficient
to cover the 2024 Bridge Warrant Shares (and such reverse split is effectuated) (&#8220;Bridge Warrant Stockholder Approval&#8221;),
and will expire on the fifth (5th) anniversary of the date on which Bridge Warrant Stockholder Approval is received and deemed effective
under Delaware law. The exercise price of the 2024 Bridge Warrants is subject to downward adjustment upon any subsequent transaction
at a price lower than the exercise price then in effect. Following the March&#160;2024 Registered Direct Offering and Concurrent Private
Placement, the exercise price of the 2024 Bridge Warrants was downward adjusted to $4.50 per share. Following the Reverse Stock Split,
the 2024 Bridge Warrants are immediately exercisable.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise price and the number of shares of Common Stock issuable upon exercise of each 2024 Bridge Warrant are subject to appropriate
adjustments in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications or similar
events affecting the common stock. Pursuant to a one-time reset right under the terms of such warrants, the exercise price of such warrants
was reset at $1.8302 as a result of the Reverse Stock Split, and all such warrants were exercised for cash at such price shortly after
the price reset became effective.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing of the 2024 Bridge Private Placement occurred on January&#160;23, 2024.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Repayment
of 2024 Bridge Promissory Notes</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
January&#160;26, 2024 and February&#160;2, 2024, the 2024 Bridge Promissory Notes were paid back in full.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Conversion
of Series&#160;B Preferred Stock</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June&#160;10, 2024, the holders of Series&#160;B Preferred Stock have converted 115,278 shares of Series&#160;B Preferred Stock into
185,319 shares of Common Stock (the &#8220;Conversion&#8221;). From January&#160;1, 2024 through June&#160;10, 2024, the holders of Series&#160;B
Preferred Stock have converted 5,000 shares of Series&#160;B Preferred Stock into 8,038 shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 31; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>February&#160;2024
Unit Offering</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February&#160;13, 2024, we completed a public offering (the &#8220;February&#160;2024 Unit Offering&#8221;) of an aggregate of 158,227
units (the &#8220;February&#160;Units&#8221;) and 867,373 pre-funded units (the &#8220;February&#160;2024 Pre-Funded Units&#8221;) for
a purchase price of $9.75 per February&#160;Unit and $9.735 per February&#160;Pre-Funded Unit, resulting in aggregate gross proceeds
of approximately $10 million. Each February&#160;Unit consists of (i)&#160;one share of Common Stock, and (ii)&#160;one warrant (the
 &#8220;February&#160;2024 Warrants&#8221;) to purchase one share of Common Stock (the &#8220;February&#160;2024 Warrant Shares&#8221;),
at an initial exercise price of $9.75 per share. Each February&#160;2024 Pre-Funded Unit consists of (i)&#160;one pre-funded warrant
(the &#8220;February&#160;2024 Pre-Funded Warrants&#8221;) to purchase one share of common stock, and (ii)&#160;one February&#160;2024
Warrant. The February&#160;2024 Warrants are not exercisable until after the date that stockholder approval is obtained to approve each
of (i)&#160;the issuance of the February&#160;2024 Warrant Shares, as may be required by the applicable rules&#160;and regulations of
Nasdaq, and (ii)&#160;if necessary, a proposal to amend the Certificate of Incorporation to increase the authorized share capital of
the Company to an amount sufficient to cover the February&#160;2024 Warrant Shares or to effectuate a reverse stock split whereby the
authorized share capital is not split and is sufficient to cover the February&#160;Warrant Shares (and such reverse split is effectuated)
(&#8220;Stockholder Approval for February&#160;2024 Unit Offering&#8221;), and will expire on the fifth (5th) anniversary of the date
on which Stockholder Approval for February&#160;2024 Unit Offering is received and deemed effective under Delaware law. The February&#160;2024
Pre-Funded Warrants are immediately exercisable for one share of common stock at an exercise price of $0.015 per share, and will remain
exercisable until exercised in full.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to the holders of February&#160;2024 Warrants who did not execute the Warrant Amendment Agreement (as defined below), if at any
time on or after the date of issuance there occurs any stock split, stock dividend, stock combination, recapitalization or other similar
transaction involving our common stock (including the Reverse Stock Split), the lowest daily volume weighted average price during the
period commencing five (5)&#160;consecutive trading days immediately preceding and the five consecutive trading days immediately following
such event is less than the exercise price of the February&#160;2024 Warrants then in effect, then such exercise price shall be reduced
to the lowest daily volume weighted average price during such ten (10)-day period and the number of shares of Common Stock issuable upon
exercise will be increased such that the aggregate exercise price, after taking into account the decrease, shall be equal to the aggregate
exercise price on the issuance date. With respect to the holders of February&#160;2024 Warrants who executed the Warrant Amendment Agreement,
the right pursuant to such provision was one-time only, and they do not have this right in any future reverse stock splits or similar
events under the terms of their February&#160;2024 Warrants. Immediately prior to the Reverse Stock Split, an aggregate of 1,025,600
shares of Common Stock were issuable upon exercise of all February&#160;2024 Warrants. As a result of the Reverse Stock Split, the aggregate
number of shares of Common Stock issuable upon exercise of all February&#160;2024 Warrants was increased by 4,438,065 to an aggregate
of 5,463,665, based on a new per share exercise price of $1.8302.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the February&#160;2024 Unit Offering, on February&#160;12, 2024, we entered into a securities purchase agreement (the
 &#8220;February&#160;2024 Purchase Agreement&#8221;) with certain investors, pursuant to which we agreed, subject to certain exemptions,
not to offer for sale, issue, sell, contract to sell, pledge or otherwise dispose of any of its shares of Common Stock or securities
convertible into Common Stock until the date of the Stockholder Approval for February&#160;2024 Unit Offering, unless we are required
to complete a financing prior to the date of the Stockholder Approval for February&#160;2024 Unit Offering, in order to satisfy Nasdaq&#8217;s
continued listing requirements.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also
in connection with the February&#160;2024 Unit Offering, on February&#160;12, 2024, we entered into a placement agency agreement (the
 &#8220;February&#160;Placement Agency Agreement&#8221;) with Maxim, pursuant to which Maxim agreed to act as placement agent on a &#8220;best
efforts&#8221; basis in connection with the February&#160;2024 Unit Offering. We paid Maxim an aggregate fee equal to 7.0% of the gross
proceeds raised in the February&#160;2024 Unit Offering and reimbursed Maxim $75,000 for expenses in connection therewith.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Series&#160;B
Repurchase and Cancellation Transaction</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February&#160;5, 2024, we entered into side letter agreements (the &#8220;February&#160;2024 Side Letters&#8221;) with certain holders
of Series&#160;B Preferred Warrants, whereby such holders agreed to, among others, (i)&#160;allow us to repurchase all 62,657 outstanding
shares of Series&#160;B Preferred Stock then held by them at $100 per share with a portion of the proceeds received from the February&#160;2024
Unit Offering, and (ii)&#160;cancel all outstanding Series&#160;B Preferred Warrants to purchase up to 81,315 shares of Series&#160;B
Preferred Stock, then held by them, immediately prior to the closing of the February&#160;2024 Unit Offering (collectively, the &#8220;Series&#160;B
Repurchase and Cancellation Transaction&#8221;). We used approximately $6.3 million of the proceeds from the February&#160;2024 Offering
to repurchase 62,657 shares of the Company&#8217;s Series&#160;B Preferred Stock, at $100 per share.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>March&#160;2024
Warrant Amendment</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March&#160;26, 2024, we entered into a warrant amendment agreement (the &#8220;Warrant Amendment Agreement&#8221;) with certain holders
of (i)&#160;the New Inducement Warrants, as amended by that certain warrant amendment agreement, dated as of February&#160;5, 2024, (ii)&#160;the
2024 Bridge Warrants, and (iii)&#160;the February&#160;Warrants (together with the New Inducement Warrants, as amended and the 2024 Bridge
Warrants, the &#8220;Original Warrants&#8221;), whereby the holders agreed to (i)&#160;amend the exercisability provision in the New
Inducement Warrants, as amended and the 2024 Bridge Warrants so such warrants shall not be exercisable until one or more certificates
of amendment to the Certificate of Incorporation are filed with the Secretary of State of the State of Delaware to effectuate an increase
in authorized shares of capital stock of the Company and a reverse stock split of the Company&#8217;s outstanding shares of common stock;
and (ii)&#160;remove certain exercise price reset, right to reprice and/or share adjustment provisions in the Original Warrants, to be
effective following the first adjustments following the Reverse Stock Split, pursuant to each of Section&#160;2(c)&#160;in the New Inducement
Warrants, as amended and the 2024 Bridge Warrants and Section&#160;3(f)&#160;of the February&#160;Warrants, as applicable, for purposes
of compliance with Nasdaq.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 32; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>March&#160;2024
Registered Direct Offering and Concurrent Private Placement</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March&#160;26, 2024, we entered into a securities purchase agreement (the &#8220;March&#160;2024 Purchase Agreement&#8221;) with the
Investor Warrant Holders. Under the March&#160;2024 Purchase Agreement, we agreed to issue and sell to the Investor Warrant Holders (i)&#160;in
a registered direct offering, 417,833 shares of Common Stock at $4.50 per share and pre-funded warrants to purchase up to 93,342 shares
of Common Stock at $4.485 per pre-funded warrant, and (ii)&#160;in a concurrent private placement, common stock purchase warrants (the
 &#8220;March&#160;2024 Warrants&#8221;) exercisable for an aggregate of up to 511,175 shares of Common Stock, at an initial exercise
price of $6.00 per share (the &#8220;March&#160;2024 Registered Direct Offering and Concurrent Private Placement&#8221;).</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the March&#160;2024 Purchase Agreement, we and the Investor Warrant Holders terminated the participation right granted to the Investor
Warrant Holders pursuant to the Waiver Agreement in exchange for a new form of participation right whereby for the 24-month period beginning
on March&#160;27, 2024, the Investor Warrant Holders may participate in (a)&#160;any financing offered by us that occurs on or before
September&#160;1, 2024 that is not intended to be marketed as a &#8220;public offering&#8221; under the rules&#160;of Nasdaq up to an
amount equal to 90% of such financing, and (b)&#160;any other financing offered us up to an amount equal to 40% of such financing, in
each case on the same terms, conditions and price provided to other purchasers in the applicable financing.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
March&#160;2024 Warrants contain 4.99/9.99% beneficial ownership limitations and are not exercisable until the date we receive the approval
required by the applicable rules&#160;and regulations of Nasdaq from stockholders with respect to the issuance of the March&#160;2024
Warrant Shares and will expire on the fifth anniversary of such approval.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
March&#160;2024 Registered Direct Offering and Concurrent Private Placement closed on March&#160;27, 2024 and we received gross proceeds
of approximately $2.3 million before deducting fees and other offering expenses payable by us.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to a one-time right under the terms of the March&#160;2024 Warrants and as a result of the Reverse Stock Split, the per share exercise
price for the March&#160;2024 Warrants was reduced to $1.8302 and the aggregate number of shares of Common Stock issuable upon exercise
of all March&#160;2024 Warrants was increased by 1,164,628, to an aggregate of 1,675,803, based on such price.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Initial
April&#160;2024 Registered Direct Offering and Concurrent Private Placement</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April&#160;17, 2024, we entered into a securities purchase agreement (the &#8220;Initial April&#160;2024 Purchase Agreement&#8221;) with
the Investor Warrant Holders. Under the Initial April&#160;2024 Purchase Agreement, we agreed to issue and sell to the Investor Warrant
Holders (i)&#160;in a registered direct offering, 225,834 shares of Common Stock at $3.321 per share, and (ii)&#160;in a concurrent private
placement, common stock purchase warrants (the &#8220;Initial April&#160;2024 Warrants&#8221;) exercisable for an aggregate of up to
225,834 shares of Common Stock, at an exercise price of $3.196 per share (the &#8220;Initial April&#160;2024 Registered Direct Offering
and Concurrent Private Placement&#8221;).</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Initial April&#160;2024 Warrants contain 4.99/9.99% beneficial ownership limitations, are exercisable upon issuance and expire on the
fifth anniversary of the issuance date of such warrants.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Initial April 2024 Registered Direct Offering and Concurrent Private
Placement closed on April&nbsp;19, 2024 and we received gross proceeds of approximately $750,000 before deducting fees and other offering
expenses payable by us.</P>
<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
or about April&#160;19, 2024, the Investor Warrant Holders each entered into a warrant amendment agreement with us whereby the Selling
Stockholders agreed to amend the &#8220;alternative cashless exercise&#8221; provision in Section&#160;2(c)&#160;of the Initial April&#160;2024
Warrants such that issuance of shares of Common Stock upon exercise of such &#8220;alternative cashless exercise&#8221; is subject to
stockholder approval.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Second
April&#160;2024 Registered Direct Offering and Concurrent Private Placement</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April&#160;19, 2024, we entered into a securities purchase agreement (the &#8220;Second April&#160;2024 Purchase Agreement&#8221;) with
the Investor Warrant Holders. Under the Second April&#160;2024 Purchase Agreement, we agreed to issue and sell to the Investor Warrant
Holders (i)&#160;in a registered direct offering,&#160;361,904&#160;shares of Common Stock&#160;at $5.250 per share, and (ii)&#160;in
a concurrent private placement, common stock purchase warrants (the &#8220;Second April&#160;2024 Warrants&#8221;) exercisable for an
aggregate of up to&#160;542,856&#160;shares of Common Stock, at an exercise price of $5.06 per share (the &#8220;Second April&#160;2024
Registered Direct Offering and Concurrent Private Placement&#8221;).</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Second April&#160;2024 Warrants contain 4.99/9.99% beneficial ownership limitations, are exercisable upon issuance and expire on the
fifth anniversary of the issuance date of such warrants. Issuance of shares of Common Stock upon &#8220;alternative cashless exercise&#8221;
pursuant to the terms of such warrants is subject to stockholder approval.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Second April&#160;2024 Registered Direct Offering and Concurrent Private Placement closed on April&#160;23, 2024 and we received gross
proceeds of approximately $1.9 million before deducting fees and other offering expenses payable by us.</FONT></P>


<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 33; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Third
April&#160;2024 Registered Direct Offering and Concurrent Private Placement</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April&#160;26, 2024, we entered into a securities purchase agreement (the &#8220;Third April&#160;2024 Purchase Agreement&#8221;) with
the Investor Warrant Holders. Under the Third April&#160;2024 Purchase Agreement, we agreed to issue and sell to the Investor Warrant
Holders (i)&#160;in a registered direct offering,&#160;418,845&#160;shares of Common Stock&#160;at $5.73 per share, and (ii)&#160;in
a concurrent private placement, common stock purchase warrants (the &#8220;Third April&#160;2024 Warrants&#8221;) exercisable for an
aggregate of up to&#160;418,845 shares of Common Stock, at an exercise price of $5.60 per share (the &#8220;Third April&#160;2024 Registered
Direct Offering and Concurrent Private Placement&#8221;).</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Third April&#160;2024 Warrants contain 4.99/9.99% beneficial ownership limitations, are exercisable upon issuance and expire on the fifth
anniversary of the issuance date of such warrants. Issuance of shares of Common Stock upon &#8220;alternative cashless exercise&#8221;
pursuant to the terms of such warrants is subject to stockholder approval.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Third April&#160;2024 Registered Direct Offering and Concurrent Private Placement closed on April&#160;30, 2024 and we received gross
proceeds of approximately $2.4 million before deducting fees and other offering expenses payable by us.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Initial
May&#160;2024 Registered Direct Offering and Concurrent Private Placement</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May&#160;13, 2024, we entered into a securities purchase agreement (the &#8220;Initial May&#160;2024 Purchase Agreement&#8221;) with
the Investor Warrant Holders. Under the Initial May&#160;2024 Purchase Agreement, we agreed to issue and sell to the Investor Warrant
Holders (i)&#160;in a registered direct offering, 785,000 shares of Common Stock at $3.31 per share, and (ii)&#160;in a concurrent private
placement, common stock purchase warrants (the &#8220;Initial May&#160;2024 Warrants&#8221;) exercisable for an aggregate of up to 785,000
shares of Common Stock, at an exercise price of $3.18 per share (the &#8220;Initial May&#160;2024 Registered Direct Offering and Concurrent
Private Placement&#8221;).</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Initial May&#160;2024 Warrants contain 4.99/9.99% beneficial ownership limitations, are exercisable upon issuance and expire on the fifth
anniversary of the issuance date of such warrants. Issuance of shares of Common Stock upon &#8220;alternative cashless exercise&#8221;
pursuant to the terms of such warrants is subject to stockholder approval.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Initial May&#160;2024 Registered Direct Offering and Concurrent Private Placement closed on May&#160;15, 2024 and we received gross proceeds
of approximately $2.6 million before deducting fees and other offering expenses payable by us.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Second
May&#160;2024 Registered Direct Offering and Concurrent Private Placement</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May&#160;15, 2024, we entered into a securities purchase agreement (the &#8220;Second May&#160;2024 Purchase Agreement&#8221;) with the
Investor Warrant Holders. Under the Second May&#160;2024 Purchase Agreement, we agreed to issue and sell to the Investor Warrant Holders
(i)&#160;in a registered direct offering, 675,000 shares of Common Stock at $3.61 per share, and (ii)&#160;in a concurrent private placement,
common stock purchase warrants (the &#8220;Second May&#160;2024 Warrants&#8221;) exercisable for an aggregate of up to 675,000 shares
of Common Stock, at an exercise price of $3.48 per share (the &#8220;Second May&#160;2024 Registered Direct Offering and Concurrent Private
Placement&#8221;).</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Second May&#160;2024 Warrants contain 4.99/9.99% beneficial ownership limitations, are exercisable upon issuance and expire on the fifth
anniversary of the issuance date of such warrants. Issuance of shares of Common Stock upon &#8220;alternative cashless exercise&#8221;
pursuant to the terms of such warrants is subject to stockholder approval.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Second May&#160;2024 Registered Direct Offering and Concurrent Private Placement closed on May&#160;17, 2024 and we received gross proceeds
of approximately $2.4 million before deducting fees and other offering expenses payable by us.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
September&#160;2024 Transactions</I></B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September&#160;10, 2024, the Company entered into the Exchange Agreements with holders of the February&#160;2024 Warrants. Pursuant to
the Exchange Agreements, the Investor Warrant Holders agreed to exchange their February&#160;2024 Warrants for the Exchange Warrants
exercisable for an aggregate of up to 5,135,182 shares of Common Stock, at an exercise price of $2.21 per share.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also
on September&#160;10, 2024, following completion of the transactions contemplated by the Exchange Agreements, the Company entered into
the September&#160;Inducement Agreements with the Investor Warrant Holders, pursuant to which the Company agreed, as consideration for
exercising all or part of the Exchange Warrants held by any such Investor Warrant Holder on or prior to September&#160;30, 2024, to issue
to such Investor Warrant Holder one or more September&#160;Inducement Warrants, exercisable for up to a number of shares of Common Stock
equal to 65% of the number of Exchange Warrant Shares issued upon exercise of the Exchange Warrants under the September&#160;Inducement
Agreements. Under the terms of the September&#160;Inducement Agreements, the Investor Warrant Holders were required to exercise an aggregate
of 904,977 Exchange Warrants on September&#160;10, 2024, for aggregate gross proceeds of approximately $2.0 million. Pursuant to the
September&#160;Inducement Agreements, September&#160;Inducement Warrants exercisable for up to an aggregate of 1,448,609 September&#160;Inducement
Warrant Shares were issued to the Investor Warrant Holders.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 34; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also
on September&#160;10, 2024, following completion of the transactions contemplated by the September&#160;Inducement Agreements, the Company
entered into a Side Letter Agreement with each of the Investor Warrant Holders with respect to (i)&#160;those certain common stock purchase
warrants issued to the Investor Warrant Holders on March&#160;27, 2024, as amended (the &#8220;March&#160;2024 Warrants&#8221;), (ii)&#160;those
certain common stock purchase warrants of the Company, originally issued to the Investor Warrant Holders on April&#160;19, 2024, as amended
(the &#8220;1st April&#160;2024 Warrants&#8221;), (iii)&#160;those certain common stock purchase warrants of the Company, originally
issued to the Investor Warrant Holders on April&#160;23, 2024 (the &#8220;2nd April&#160;2024 Warrants&#8221;), (iv)&#160;those certain
common stock purchase warrants of the Company, originally issued to the Investor Warrant Holders on April&#160;30, 2024 (the &#8220;3rd
April&#160;2024 Warrants&#8221;), (v)&#160;those certain common stock purchase warrants of the Company, originally issued to the Investor
Warrant Holders on May&#160;15, 2024 (the &#8220;1st May&#160;2024 Warrants&#8221;), and (vi)&#160;those certain common stock purchase
warrants of the Company, originally issued to the Investor Warrant Holders on May&#160;17, 2024 (the &#8220;2nd May&#160;2024 Warrants&#8221;,
and together with the March&#160;2024 Warrants, the 1st April&#160;2024 Warrants, the 2nd April&#160;2024 Warrants, the 3rd April&#160;2024
Warrants, and the 1st May&#160;2024 Warrants, the &#8220;Original Warrants&#8221;), which Investor Warrant Holders are also parties to
(i)&#160;that certain securities purchase agreement, dated as of March&#160;26, 2024 (the &#8220;March&#160;2024 Purchase Agreement&#8221;),
(ii)&#160;that certain securities purchase agreement, dated as of April&#160;17, 2024 (the &#8220;1<SUP>st</SUP>&#160;April&#160;2024
Purchase Agreement&#8221;), (iii)&#160;that certain securities purchase agreement, dated as of April&#160;19, 2024 (the &#8220;2<SUP>nd</SUP>&#160;April&#160;2024
Purchase Agreement&#8221;), (iv)&#160;that certain securities purchase agreement, dated as of April&#160;26, 2024 (the &#8220;3<SUP>rd</SUP>&#160;April&#160;2024
Purchase Agreement&#8221;), (v)&#160;that certain securities purchase agreement, dated as of May&#160;13, 2024 (the &#8220;1<SUP>st</SUP>&#160;May&#160;2024
Purchase Agreement&#8221;), and (vi)&#160;that certain securities purchase agreement, dated as of May&#160;15, 2024 (the &#8220;2<SUP>nd</SUP>&#160;May&#160;2024
Purchase Agreement&#8221;, and together with the March&#160;2024 Purchase Agreement, the 1<SUP>st</SUP>&#160;April&#160;2024 Purchase
Agreement, the 2<SUP>nd</SUP>&#160;April&#160;2024 Purchase Agreement, the 3<SUP>rd</SUP>&#160;April&#160;2024 Purchase Agreement, and
the 1<SUP>st</SUP>&#160;May&#160;Purchase Agreement, the &#8220;Original Purchase Agreements&#8221;) with the Company.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Side Letter Agreements, (a)&#160;the Investor Warrant Holders agreed to (i)&#160;amend the &#8220;Fundamental Transaction&#8221;
provisions in the Original Warrants, so that the &#8220;Black Scholes Value&#8221; clauses in such provisions will be removed in their
entirety, effective immediately following receipt of stockholder approval of (a)&#160;the issuance of the shares of Common Stock issuable
pursuant to the exercise of the Side Letter Warrants and (b)&#160;the issuance of shares of Common Stock pursuant to the alternative
cashless exercise provisions of the 1<SUP>st</SUP>&#160;April&#160;2024 Warrants, the 2<SUP>nd</SUP>&#160;April&#160;2024 Warrants, the
3<SUP>rd</SUP>&#160;April&#160;2024 Warrants, the 1<SUP>st</SUP>&#160;May&#160;2024 Warrants, and the 2<SUP>nd</SUP>&#160;May&#160;2024
Warrants, (ii)&#160;remove the &#8220;Stockholder Meeting&#8221; provisions in the March&#160;2024 Purchase Agreement, effective immediately,
(iii)&#160;amend the &#8220;Stockholder Meeting&#8221; provisions in the remaining Original Purchase Agreements such that the Company
is first obligated to call a stockholder meeting to approve the issuance of the shares of Common Stock issuable upon exercise of the
Original Warrants no later than December&#160;31, 2024, and thereafter, to re-call a stockholder meeting, if necessary, every six months
until such stockholder approval is obtained, and (iv)&#160;remove the &#8220;Subsequent Equity Sales&#8221; and &#8220;Registration Statement&#8221;
provisions in the March&#160;2024 Purchase Agreement; and (b)&#160;as inducements to and in consideration for each Investor Warrant Holder&#8217;s
agreement to amend the Original Warrants and the Original Purchase Agreements in accordance with the applicable Side Letter Agreement,
the Company agreed to issue to the Investor Warrant Holders the Side Letter Shares and the Side Letter Warrants, such Side Letter Shares
to be issued upon execution of the Side letter Agreements, and such Side Letter Warrants to be issued upon the receipt of stockholder
approval referred to in (a)(i)&#160;above. On December&#160;20, 2024, such stockholder approval was received, and the Side Letter Warrants
were issued.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Side Letter Warrants may be exercised, in certain circumstances, on a cashless basis pursuant to the formula contained such warrants.&#160;The
holder of a Side Letter Warrant may effect an &#8220;alternative cashless exercise.&#8221;&#160;In such event, the aggregate number of
shares of Common Stock issuable in such alternative cashless exercise pursuant to any given notice of exercise electing to effect an
alternative cashless exercise shall equal the product of (x)&#160;the aggregate number of shares of Common Stock that would be issuable
upon exercise of the Side Letter Warrant in accordance with the terms of the Side Letter Warrant if such exercise were by means of a
cash exercise rather than a cashless exercise and (y)&#160;1.0.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than the transactions described above, in &#8220;The September&#160;2024 Transaction,&#8221; &#8220;The February&#160;2025 Transaction&#8221;
and &#8220;The April&#160;2025 Transaction,&#8221; we have had no material relationships with the Selling Stockholders in the last three
(3)&#160;years.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 35; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="km_006"></A>USE
OF PROCEEDS</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will not receive any of the proceeds from the sale of the Warrant Shares by the Selling Stockholders pursuant to this prospectus.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may receive up to approximately $23,768,041 in gross proceeds from cash exercises of the Warrants, if exercised in full, based on the
current per share exercise prices of $2.21 for the September&#160;2024 Warrants, $1.425 for the Placement Agent Warrants and $0.8615
for the 2025 Investor Warrants. The exercise price for the 2025 Investor Warrants may be adjusted downwards pursuant to the terms of
anti-dilution features contained therein under certain circumstances, and if any of the 2025 Investor Warrants are exercised at such
lower price, we will receive less aggregate gross proceeds. If the Warrants are exercised pursuant to the cashless exercise provisions
contained therein, we will also receive less aggregate gross proceeds. We intend to use a portion of the net proceeds we may receive
from any cash exercises of the Warrants for working capital, capital expenditures, product development, and other general corporate purposes,
including investments in sales and marketing in the United States and internationally.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders will pay any agent&#8217;s commissions and expenses they incur for brokerage, accounting, tax or legal services
or any other expenses that they incur in disposing of the shares of Common Stock. We will bear all other costs, fees and expenses incurred
in effecting the registration of the shares of Common Stock covered by this prospectus and any prospectus supplement. These may include,
without limitation, all registration and filing fees, SEC filing fees and expenses of compliance with state securities or &#8220;blue
sky&#8221; laws.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot predict when or if the Warrants will be exercised, and it is possible that the Warrants may expire and never be exercised. In
addition, the Investor Warrants are not exercisable until the date that we receive stockholder approval for the issuance of the Investor
Warrant Shares. As a result, we may never receive meaningful, or any, cash proceeds from the exercise of the Investor Warrants, and we
cannot plan on any specific uses of any proceeds we may receive beyond the purposes described herein.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
 &#8220;Plan of Distribution&#8221; elsewhere in this prospectus for more information.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 36; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="km_007"></A>DESCRIPTION OF SECURITIES THAT THE SELLING STOCKHOLDERS
ARE OFFERING</B></P>
<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">The Selling
Stockholders are offering for resale up to an aggregate of 22,728,368 shares of Common Stock. The terms of our shares of Common Stock
are contained in our Certificate of Incorporation and our bylaws, each as amended to date and each as filed or incorporated by reference
as exhibits to our </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000141057825000600/dvlt-20241231x10k.htm">Annual
Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2024</A>. For a description of our Common Stock, see (i)&nbsp;our
Registration Statement on <A HREF="https://www.sec.gov/Archives/edgar/data/1682149/000114420418039919/tv499143_8-a12b.htm">Form&nbsp;8-A,
filed with the SEC on July&nbsp;25, 2018</A> under Section&nbsp;12(b)&nbsp;of the Exchange Act, including any amendments or reports filed
for the purpose of updating such description and (ii)&nbsp;<A HREF="https://www.sec.gov/Archives/edgar/data/1682149/000141057825000600/dvlt-20241231xex4d2.htm">Exhibit&nbsp;4.2</A>&mdash;Description
of Securities Registered Pursuant to Section&nbsp;12 of the Exchange Act of 1934, to our Annual Report on Form&nbsp;10-K for the fiscal
year ended December&nbsp;31, 2024, filed with the SEC on March&nbsp;31, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Certificate of Incorporation authorizes the issuance of up to 300,000,000
shares of Common Stock and up to 20,000,000 shares of blank check preferred stock, par value $0.0001 per share, of which 375,000 shares
are designated as Series&nbsp;B Preferred Stock. The Board may establish the rights and preferences of the preferred stock from time to
time.</P>
<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 37; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="km_008"></A>PLAN
OF DISTRIBUTION</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders and any of their respective pledgees, assignees and successors-in-interest may, from time to time, sell, transfer
or otherwise dispose of any or all of their securities covered hereby on any trading market, stock exchange or other trading facility
on which the securities are traded or in private transactions. These sales may be at fixed prices, at prevailing market rates at the
time of sale, at prices related to the prevailing market price, at varying prices determined at the time of sale, or at negotiated prices.
The Selling Stockholders may use any one or more of the following methods when selling securities:</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 12pt">
  <TR>
    <TD STYLE="width: 3%; vertical-align: top"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD>
    <TD STYLE="width: 97%; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">block trades in which the broker-dealer will attempt to sell the securities as agent, but may position and resell a portion of the block as principal to facilitate the transaction;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 12pt">
  <TR>
    <TD STYLE="width: 3%; vertical-align: top"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD>
    <TD STYLE="width: 97%; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an exchange distribution in accordance with the rules&#160;of the applicable exchange;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately negotiated transactions;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">settlement of short sales;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in transactions through broker-dealers that agree with the Selling Stockholders to sell a specified number of such securities at a stipulated price per security;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a combination of any such methods of sale; or</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any other method permitted pursuant to applicable law.</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders may also sell securities under Rule&#160;144 under the Securities Act, if available, rather than under this prospectus.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker-dealers
engaged by the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions
or discounts from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser)
in amounts to be negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency transaction not in
excess of a customary brokerage commission in compliance with FINRA Rule&#160;2121; and in the case of a principal transaction a markup
or markdown in compliance with FINRA Rule&#160;2121.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the sale of the securities covered hereby, the Selling Stockholders may enter into hedging transactions with broker-dealers
or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they
assume. The Selling Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan
or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option
or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the
delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer
or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be &#8220;underwriters&#8221;
within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers
or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts
under the Securities Act. We are requesting that each Selling Stockholder inform us that it does not have any written or oral agreement
or understanding, directly or indirectly, with any person to distribute the securities. We will pay certain fees and expenses incurred
by us incident to the registration of the securities.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
the Selling Stockholders may be deemed to be &#8220;underwriters&#8221; within the meaning of the Securities Act, they will be subject
to the prospectus delivery requirements of the Securities Act, including Rule&#160;172 thereunder. In addition, any securities covered
by this prospectus which qualify for sale pursuant to Rule&#160;144 under the Securities Act may be sold under Rule&#160;144 rather than
under this prospectus. We are requesting that each Selling Stockholder confirm that there is no underwriter or coordinating broker acting
in connection with the proposed sale of the resale securities by the Selling Stockholder.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 38; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to keep this prospectus effective until the earlier of (i)&#160;the date on which the securities may be resold by the Selling
Stockholders without registration and without regard to any volume or manner-of-sale limitations by reason of Rule&#160;144, without
the requirement for us to be in compliance with the current public information requirement under Rule&#160;144 under the Securities Act
or any other rule&#160;of similar effect or (ii)&#160;all of the securities have been sold pursuant to this prospectus or Rule&#160;144
under the Securities Act or any other rule&#160;of similar effect. The resale securities will be sold only through registered or licensed
brokers or dealers if required under applicable state securities laws. In addition, in certain states, the securities covered hereby
may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration
or qualification requirement is available and is complied with.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
applicable rules&#160;and regulations under the Exchange Act, any person engaged in the distribution of the resale of the securities
may not simultaneously engage in market making activities with respect to the Common Stock for the applicable restricted period, as defined
in Regulation M, prior to the commencement of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions
of the Exchange Act and the rules&#160;and regulations thereunder, including Regulation M, which may limit the timing of purchases and
sales of Common Stock by the Selling Stockholders or any other person. We will make copies of this prospectus available to the Selling
Stockholders and are informing the Selling Stockholders of the need to deliver a copy of this prospectus to each purchaser at or prior
to the time of the sale (including by compliance with Rule&#160;172 under the Securities Act).</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 39; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="km_009"></A>DISCLOSURE
OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITY</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling the
registrant pursuant to the foregoing provisions, the registrant has been informed that in the opinion of the SEC such indemnification
is against public policy as expressed in the Securities Act and is, therefore, unenforceable.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="km_010"></A>LEGAL
MATTERS</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
validity of the issuance of the securities offered hereby will be passed upon for us by Sullivan&#160;&amp; Worcester LLP, New York,
New York.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="km_011"></A>EXPERTS</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Our consolidated financial statements as of December&nbsp;31, 2024
and 2023 and for each of the two years in the period ended December&nbsp;31, 2024, incorporated in this prospectus by reference to the
<A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000141057825000600/dvlt-20241231x10k.htm">Annual Report on Form&nbsp;10-K
for the year ended December&nbsp;31, 2024</A>, have been so incorporated in reliance on the report (which contains an explanatory paragraph
relating to the Company&rsquo;s ability to continue as a going concern as described in Note 2 to the consolidated financial statements)
of BPM LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.</P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">The consolidated financial statements of CompuSystems,&nbsp;Inc. for the fiscal years ended December&nbsp;31, 2024 and 2023 incorporated
in this prospectus by reference to the&nbsp;<A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925061666/tm2518588d1_8ka.htm">Current
Report on Form&nbsp;8-K filed with the SEC on June&nbsp;23, 2025</A>, have been so incorporated in reliance on the report of BG Advisors
CPA,&nbsp;Ltd., an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.</P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="km_012"></A>WHERE
YOU CAN FIND MORE INFORMATION</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus constitutes a part of a registration statement on Form&#160;S-3 filed under the Securities Act. As permitted by the SEC&#8217;s
rules, this prospectus and any prospectus supplement, which form a part of the registration statement, do not contain all the information
that is included in the registration statement. You will find additional information about us in the registration statement and its exhibits.
Any statements made in this prospectus or any prospectus supplement concerning legal documents are not necessarily complete and you should
read the documents that are filed as exhibits to the registration statement or otherwise filed with the SEC for a more complete understanding
of the document or matter.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
can read our electronic SEC filings, including such registration statement, on the internet at the SEC&#8217;s website at <I>www.sec.gov</I>.
We are subject to the information reporting requirements of the Exchange Act, and we file reports, proxy statements and other information
with the SEC. These reports, proxy statements and other information will be available at the website of the SEC referred to above. We
also maintain a website at <I>www.datavaultsite.com</I>, at which you may access these materials free of charge as soon as reasonably
practicable after they are electronically filed with, or furnished to, the SEC. However, the information contained in or accessible through
our website is not part of this prospectus or the registration statement of which this prospectus forms a part, and investors should
not rely on such information in making a decision to purchase our securities in this offering.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 40; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="km_013"></A>INCORPORATION
OF CERTAIN DOCUMENTS BY REFERENCE</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC permits us to &#8220;incorporate by reference&#8221; into this prospectus the information contained in documents that we file with
the SEC, which means that we can disclose important information to you by referring you to those documents. Information that is incorporated
by reference is considered to be part of this prospectus and you should read it with the same care that you read this prospectus. Information
that we file later with the SEC will automatically update and supersede the information that is either contained, or incorporated by
reference, in this prospectus, and will be considered to be a part of this prospectus from the date those documents are filed. We have
filed with the SEC and incorporate by reference in this prospectus, except as superseded, supplemented or modified by this prospectus,
the documents listed below:</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000141057825000600/dvlt-20241231x10k.htm">our Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2024, filed with the SEC on March&nbsp;31, 2025;</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000141057825001273/dvlt-20250331x10q.htm" STYLE="-sec-extract: exhibit">our Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2025, filed with the SEC on May 14, 2025;</A></FONT><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our Current Reports on Form&nbsp;8-K filed with the
    SEC on </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925001395/tm252064d2_8k.htm"><FONT STYLE="font-size: 10pt">January&nbsp;6,
    2025</FONT></A><FONT STYLE="font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925001736/tm252064d1_8k.htm"><FONT STYLE="font-size: 10pt">January&nbsp;7,
    2025</FONT></A><FONT STYLE="font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925002022/tm252259d1_8ka.htm"><FONT STYLE="font-size: 10pt">January&nbsp;8,
    2025</FONT></A><FONT STYLE="font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925012422/tm256455d1_8k.htm"><FONT STYLE="font-size: 10pt">February&nbsp;13,
    2025</FONT></A> <FONT STYLE="font-size: 10pt">(the first Current Report on Form&nbsp;8-K filed on such date), </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925012760/tm256455d2_8k.htm"><FONT STYLE="font-size: 10pt">February&nbsp;13,
    2025</FONT></A> <FONT STYLE="font-size: 10pt">(the second Current Report on Form&nbsp;8-K filed on such date), </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925014230/tm256656d2_8k.htm"><FONT STYLE="font-size: 10pt">February&nbsp;14,
    2025</FONT></A><FONT STYLE="font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925019129/tm257883d1_8k.htm"><FONT STYLE="font-size: 10pt">February&nbsp;28,
    2025</FONT></A><FONT STYLE="font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925024238/tm259436d1_8k.htm"><FONT STYLE="font-size: 10pt">March&nbsp;17,
    2025</FONT></A><FONT STYLE="font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925029648/tm2510880d1_8k.htm"><FONT STYLE="font-size: 10pt">March&nbsp;31,
    2025</FONT></A> <FONT STYLE="font-size: 10pt">(the first Current Report on Form&nbsp;8-K filed on such date), </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925029947/tm2510880d2_8k.htm"><FONT STYLE="font-size: 10pt">March&nbsp;31,
    2025</FONT></A> <FONT STYLE="font-size: 10pt">(the second Current Report on Form&nbsp;8-K filed on such date), </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925031132/tm2511063d1_8k.htm"><FONT STYLE="font-size: 10pt">April&nbsp;2,
    2025</FONT></A><FONT STYLE="font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925032260/tm2511578d1_8k.htm"><FONT STYLE="font-size: 10pt">April&nbsp;4,
    2025</FONT></A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925034671/tm2512185d1_8k.htm"><FONT STYLE="font-size: 10pt">April&nbsp;14,
    2025</FONT></A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925046741/tm2514424d1_8k.htm"><FONT STYLE="font-size: 10pt">May&nbsp;9,
    2025</FONT></A><FONT STYLE="font-size: 10pt">,&nbsp;</FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925046773/tm2514540d1_8ka.htm"><FONT STYLE="font-size: 10pt">May&nbsp;9,
    2025</FONT></A><FONT STYLE="font-size: 10pt">,&nbsp;</FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925049498/tm2515254d1_8k.htm"><FONT STYLE="font-size: 10pt">May&nbsp;15,
    2025</FONT></A><FONT STYLE="font-size: 10pt">,&nbsp;</FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925050650/tm2515584d1_8k.htm"><FONT STYLE="font-size: 10pt">May&nbsp;20,
    2025</FONT></A><FONT STYLE="font-size: 10pt">,&nbsp;</FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925051079/tm2515584d2_8k.htm"><FONT STYLE="font-size: 10pt">May&nbsp;20,
    2025</FONT></A><FONT STYLE="font-size: 10pt">,&nbsp;</FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925061666/tm2518588d1_8ka.htm"><FONT STYLE="font-size: 10pt">June&nbsp;23,
    2025</FONT></A><FONT STYLE="font-size: 10pt">&nbsp;and <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925067407/tm2520617d1_8k.htm" STYLE="-sec-extract: exhibit">July 11, 2025</A> (except for Item 2.02 and Item 7.01 of any Current Report on
    Form&nbsp;8-K which are not deemed &ldquo;filed&rdquo; for purposes of Section&nbsp;18 of the Exchange Act and are not incorporated
    by reference in this prospectus); and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the description of our Common Stock contained in (i)&nbsp;our registration statement on </FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1682149/000114420418039919/tv499143_8-a12b.htm"><FONT STYLE="font-size: 10pt">Form&nbsp;8-A, filed with the SEC on July&nbsp;25, 2018</FONT></A> <FONT STYLE="font-size: 10pt">under Section&nbsp;12(b)&nbsp;of the Exchange Act, including any amendments or reports filed for the purpose of updating such description and (ii)&nbsp;</FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1682149/000141057825000600/dvlt-20241231xex4d2.htm"><FONT STYLE="font-size: 10pt">Exhibit&nbsp;4.2</FONT></A><FONT STYLE="font-size: 10pt">&mdash;Description of Securities Registered Pursuant to Section&nbsp;12 of the Exchange Act, to our Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2024, filed with the SEC on March&nbsp;31, 2025.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also incorporate by reference into this prospectus additional documents that we may file with the SEC under Sections 13(a), 13(c), 14
or 15(d)&#160;of the Exchange Act after the date hereof but before the completion or termination of this offering (excluding any information
not deemed &#8220;filed&#8221; with the SEC).</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
statement contained in a previously filed document is deemed to be modified or superseded for purposes of this prospectus to the extent
that a statement contained in this prospectus or in a subsequently filed document incorporated by reference herein modifies or supersedes
the statement, and any statement contained in this prospectus is deemed to be modified or superseded for purposes of this prospectus
to the extent that a statement contained in a subsequently filed document incorporated by reference herein modifies or supersedes the
statement.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will provide, without charge, to each person to whom a copy of this prospectus is delivered, including any beneficial owner, upon the
written or oral request of such person, a copy of any or all of the documents incorporated by reference herein, including exhibits. Requests
should be directed to:</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Datavault
AI Inc.</FONT><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15268
NW Greenbrier Pkwy</FONT><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beaverton,
OR 97006</FONT><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(408)
627-4716</FONT><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">info@wisatechnologies.com</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Copies
of these filings are also available on our website at <I>www.datavaultsite.com.</I> For other ways to obtain a copy of these filings,
please refer to &#8220;Where You Can Find More Information&#8221; above.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 41; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="text-align: center; font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm252006d4_s3img002.jpg" ALT="" STYLE="width: 623px; height: 173px">&nbsp;</P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Datavault
AI Inc.</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>22,728,368
Shares of Common Stock</B></FONT><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issuable
Upon Exercise of Certain Common Stock Purchase Warrants</B></FONT><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The date of this prospectus is July 11, 2025.</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 42; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm2520064d4_s3img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2520064d4_s3img001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #! NX# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK\__ /@H!^W\WPV:^^&W
MPVOE/BHJ8M6UR!@1IH(P88B/^6_JW_+/H/G^Y48N3LA-J*NSN?VS/^"A>@_
M!;OPIX0%OXC^(&"DH)W6FEGUF(/SR?\ 3,$8ZL1P&_(GX@_$;Q+\5?%%WXC\
M6:S=:YK-T<R7-T^2!DX11T1!GA5  [ 5S\\\EU-)--(TLLC%GD<DLQ/)))ZF
MF5UQBHG+*3D%%>G? G]F_P >?M&>(CI7@S1VNHXF N]2N"8[.S![RR8./4*
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MR2,69F)R22>I)KH_B7\1=<^+7CO6?%WB.[-YK&JW#3S2<[5[*BCLBJ JCL%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWB'P[>-<Z=J$T09I;9@ZA[>X159O*?=D(Y#94J/:*+6 ****0PHHHH ****
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M&7COQQ/%G^SK.'2K5F&1NF<R2D>A"PH/I(:_4RL*CUL:TUI<****Q-0HHHH
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MA+Q1-J$&EFZCN]VFRK%+O0, ,LC#'S'M55':29,-8M'\\@4+T&*6OJS_ (*
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M--S_ .DMI77_ /!3SQA/X5_9*URVMW,<FM7UIIA=3@A2_G,/Q6$J?9C7(?\
M!(G_ )-GUW_L:;G_ -);2KO_  5HTN2__9=LIT!*V7B.TN'P.BF&XCY_&05E
M_P O#3[!^.-?L#_P2@^$%GX1^ MQXYE@5M7\5W<NV<CYDM(':)(QZ9D65CZY
M7T%?C]7[F?\ !.?Q!:^(/V/_  )]F9?,LENK.>->J2+<RG!]RK*W_ A6M7X3
M*GN?2E%%%<ITG&_&+X9Z;\8_AAXD\&:K&CVFKV;VX=USY,F,Q2CW1PKCW45_
M.Q?V4VFWUQ:7">7<02-%(F<[64X(_,5_2I=7,5G;2W$\BPP0H9))'.%50,DD
M]@!7\W?C'5H]?\7:WJ<(VQ7M]-<H",8#R,P_G712ZF%3H??7_!&[_D>_B5_V
M#;/_ -&R5^IS*&4JP!!&"#WK\L?^"-W_ "/?Q*_[!MG_ .C9*_4^LZGQ%T_A
M/P$_:^^##? ?]H+Q7X7B@,.D_:/MNE\84VDWSQ@>NS)C)]8VKH_V!?B]_P *
M=_:=\*WEQ/Y.DZQ(=$OR3A?+G(5&)[!91$Q/HIK[2_X*Z?!;^WO 'A[XEV,&
MZ[T*;^S=195Y-K,V8F8^B2_*/>>ORF1VC=75BK*<AE."#71%\T3&7NR/Z5[^
M^M]+L;F]NYEM[2WC::::0X5$4$LQ/H ":_G?^./Q*N/C%\7O%OC.YW!M8U"6
MXB1^L<.=L4?_  &,(O\ P&OTQ^.G[6BZ]_P3?T_Q/'=K_P )'XNM(_#DVT_-
M]I^9+TD=0"D4Q'IYB>HK\EJBG&UV54=['VG_ ,$K?@K_ ,+"^/4WB^]M_,TC
MP?;_ &E2PRK7DH9(!_P$"5\]BB>M?L;7S1_P3T^"_P#PIK]FG0!=0>3K7B'_
M (GE]N&&!E5?*0]QMB$>1V8MZU]+UE.7-(U@K(_GB_:(\83^/OCMX^U^=V<W
MVMW<D>[JL0E81K_P% J_A7I__!/7X16GQ@_:>\/6FIP+=:3HL<FMW<#C*R"$
MJ(U(Z%?->+(/!&1WKQ+XF6,VE_$?Q397"%+BVU6ZAD4]0RRLI'Y@U]:?\$D?
M$%KI/[3&IV-PR)+JGAVYM[<M]YI%F@E*C_@$;G_@-=,M(Z'/'61^P]%%%<1U
MA7XS_P#!4SX2V?P\_:*77=-@6WL_%=DNI2H@PHNE9HYB!_M;4<GNTC5^S%?E
M/_P6,\0VUW\3/A_HB,IN['29[N4 \A9I@JY_[\-^=:T_B,ZGPGPCX'_Y'30?
M^O\ @_\ 1BU_2*OW17\W7@?_ )'30?\ K_@_]&+7](J_=%75Z$T^I_.W\?/^
M2Z_$?_L9-2_]*I*^BO\ @E+_ ,G61?\ 8$O/_:=?.WQ^4K\=OB0",$>)=2!_
M\"I*^@_^"5MU';_M8V4;G#3Z1>1I[G:K?R4UI+X#)?$?M#1117&=9^//_!7+
M_DYW2/\ L5[7_P!*+JODKX8_\E*\)_\ 87M/_1R5]:?\%<9H9/VGM)6)MSQ^
M&+591_=;[1<G'_?)4_C7R7\,?^2E>$_^PO:?^CDKMC\*.67Q']'2_=%?A7_P
M4._Y/(^)'_7Q:_\ I'!7[J+]T5^%?_!0[_D\CXD?]?%K_P"D<%84OB-:FQG?
ML'_\G=?#/_L(M_Z)DK]YJ_!G]@__ ).Z^&?_ &$6_P#1,E?O-3J[A3V/RI_X
M+&?\E*^'W_8(F_\ 1U?GK7Z%?\%C/^2E?#[_ +!$W_HZOSUK:'PHRG\3/Z7H
M_P#5K]*=38_]6OTIU<1U&=XBUA/#WA_4]5E&Z.QM9;IAZA$+'^5?A+JT=SK6
MJ7FH7C&:\NIGGFD/5W9BS'\237[C?$VQDU3X;>++*($RW&DW<* #)W-"X'\Z
M_&1M)Y/%?HG"E:-"-:75V_4^#XFJN,J4>FOZ'1?LM_!.W^,?QL\/^'[^-FTA
M7:\OPO&Z"(;BG_ CM3/;?GM7[,6=G!I]I!:VL,=M;0(L44,2A41%& J@<
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M_P""RW_(P?"S_KUU'_T.WK\X*[*?PHY9_$S^BOX+S1CX.^!,NO\ R ;#N/\
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M^%,GQJ_9[\;^$;>/S=0O+ S6*="UU"PFA7/;<\:J3Z,:^>/^"1/_ ";/KO\
MV--S_P"DMI7V_6,M)7-8_"?S0R1O#(T<BLCJ2K*PP01U!%?:G_!-S]K[3O@1
MXGO_  5XPO!9^#=?F6:*^D/[O3[S 3>_I'(H56;^$HA.!N(VO^"D_P"QO??#
MWQ?J/Q2\)V#3^$=8F,^JPVZY_LV[<_,Y Z12,<AN@=BIQE ?@^NG2<3GU@S^
MENUNH;ZVBN;::.XMYD$D<T3!D=2,A@1P01W%2U_/U\)_VL?BS\$;-;'P?XUO
M].TU3D:?.J75LN3D[8IE94SW*@'WKL_%_P#P4-^/OC+39+"X\>3Z=:R+M?\
MLFT@LY#])8T$B_\  6%8^R9M[1'WC_P4A_; TGX:_#_5?AIX;U!+OQIKMN;6
M]^SN#_9MHXQ)O(Z22*2JKU 8L<?+N_("KMM;:CXFUF."WBN=4U6^G")'&K2S
M7$KMP !DLS$_4DT_Q%H%_P"%/$&IZ)JMN;35-,NI;*[MV8,8IHW*.F02#AE(
MR#CBMHQ458QE)R=S] ?^"-W_ "/?Q*_[!MG_ .C9*_4^ORP_X(W?\CW\2O\
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M1UKX%_X<S7W_ $5FW_\ "?;_ .2:_3NBA2<=@<5+<\+_ &/?V:9?V5_AC?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?F3_ ,%!_P#@G_+'
M/J?Q1^&6FF2*0M<ZYX?M4R4/5[F!1U!Y+H.G+#C(7]-J*J,G%W1,HJ2LS^9^
MBOUB_;2_X)KV?Q$FO_&WPK@M],\3R%IKWP_D16U^W4O$3Q%*>X.$8\_*<EOS
M^\%_L??&?Q]JTNG:3\.->$L,K0RS7UJ;."-U.&!EFV)D$'(SGVKK4DU<YG%I
MV-C]F?\ ;-\?_LQZ@(M&NAJ_A>23?<^'=0<FW<GJT9ZQ.?[R\'C<&P!7ZN_
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M+J'B:XCQ=:G)>1*J#O'$"WRIZGJV,G' 'H>J_'KX?:.I,_BO3Y,?\^KFX_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\8^(BOV#PUJ,J-]V1X#'&?\ @;X7]:]+\,_L=^)M39'UJ_L]%A/WHT)N)1^
MPO\ X]6BK);GU& R#-\Q:6&PTFGUM9?>[+\3YU:&NY^'?P+\5_$R9&TW3S!I
MY/S:C>9C@ ]CC+GV4'\*^O?!/[,W@GP:T<\MBVN7J\^?J6)%!]H\;?S!(]:]
M61%C5550JJ,!5& !Z4GB']D_7,F\-*C:J9K5LOY8[_.73Y)^IY1\)?V</#7P
MO\J^9/[9UY1G[?<H,1'_ *9)R$^O+>_.*]9HHKDE)R=Y,_<<#@,+EM%8?"4U
M"*Z+]>K?F]0HHHJ3O"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y?X@
M_P#(#?ZBOC'XB_\ (2F_ZZ&BBI9_/?B=M'T,CPG_ ,A!?]X5]E_"3_D&-]!_
M*BBF>9X9_P =GH5%%%,_I<**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm252006d4_s3img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm252006d4_s3img002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "M F\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA5-1MP%N8QQGT<#T/Z&O$S' ^R?M:?P_E_P#T,+B>?W);G74445XQW!1110
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M+]\UY';5\B_$K_DH^O?]?3?R%?75?(OQ*_Y*/KW_ %]-_(5X$3WY'J/[//\
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M?!S_ )*9IO\ NR?^@&A?"-[GU16+XP_Y$K7/^O"?_P! -;58OC#_ )$K7/\
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MFJ1RV1=M.NLF+<<F-AU0G\>/_K5Q7V<^]>M2G2J04X;,X:D7"7++H?76F_\
M(+M/^N*?^@BO"?C))M\;@?\ 3JG]:]VTW_D%VG_7%/\ T$5X1\98B_C<'_IU
MC_F:^=RRWUEW[,];&?P?N*GPHDW?$&Q'^Q)_Z :^C*^<?A/"4^(-B3_<D_\
M0#7T=1FUO;JW;_,6!_AOU"BBBO).X^+?$-L;/Q+JEL1CRKN5/R<BM3X>7:V/
MQ"T*=SA?M:H?^!?+_6M#XM::=-^)&J#&$N&6=>.S 9_7-<=;SR6MS%<1-MDB
M<.A]"#D5KNC/J?;]%4])U&+5M'L]1A(,=S"DJ\],C.*N5D:!1110 4444 %%
M%% !7F7Q.U+S+RTTY#Q$IE<>YX'Z#]:])GGCMK>2>9@L<:EF8]@*\#UC4GU;
M5KF^DR#*Y(![#L/RQ710C>5^QX.>8CDH*DMY?DBIFM3PY9'4?$-C;8RK2@M_
MNCD_H*R<UW_PQTTRWMUJ3K\L2^4A_P!H]?R'\ZZ:CY8MGR^!H>VQ$(>?X+4]
M.HHHKSC]&"O)?C/<!IM)M0>5621A]2H'\C7K5>#?$W4!?^,IT5LI;(L(^HY/
MZDUVX&-ZR?8\W,ZG+AVN[1Q!6OH3X;6_V?P+8#&/,WO^;&O =N37TSH-C_9N
M@6%F1AH8$5A_M8Y_7-=N8S]Q1\SS\I5ZDI=D:-?(OQ*_Y*/KW_7TW\A7UU7R
M+\2O^2CZ]_U]-_(5X\3Z"1ZC^SS_ ,@W7?\ KK#_ ":O::\"^!WB/1="L-83
M5=4M;)I98C&)Y NX -G&?K7IU[\4?!=C&7?7[:7_ &8,RD_]\@T-:@MCKZ^7
M?C'XCBU_QQ)':R"2VL(_LRLIX9@26(_$X_"NA\;_ !OEU.TET[PY#+:PR J]
MW+Q(1W"@?=^N<_2O'D1Y9%1%9W<X"@9))[4XH39Z7\#=*>^\>?;-N8K&!I&/
M^TWRC^9/X5M?M#*XU;1'.=A@D ^H89_F*]%^%G@UO"'A95ND U&\(FN?5./E
M3\!^I-8_QR\/OJO@Z+48$+2Z;+O; Y\MN&_4*?PHOJ.VAY5\&7B3XF6'FD#,
M<H3/][8<5]2U\3:7J5SH^J6NHV;[+BVD$B'W'K[5]7^#?'VC^,=/CDMKB.*^
M 'G6CMAT;V]1Z$42019U5<5\6I(H_AGK'FD?,B*F?[V]<5V,]Q#:PM-<2I%$
MHRSNP4#\37SO\8/B+;>))(]$T>7S-/@??-.O29QP /\ 9'//<_2I2U&WH>6V
M?_'[!_UT7^=?;PZ"OB&S_P"/V#_KHO\ .OMX=!52)B?*'Q:_Y*9J_P#OI_Z
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MN(HC1F-E4H1@J1P1Z8JK_9.G?] ^U_[\K_A1S#Y1VF_\@NT_ZXI_Z"*M4
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M5[I-:6]S"(IX(Y(QR$=00/PJM_8FE?\ 0.M/^_*_X4_:R-IY3*_NR+-H,64
M_P"F:_RKS3Q_#YGB(''_ "Q7^M>H !0   !P *K7&FV-U)YEQ9P2OC&YXP3C
M\:A2:=T>EBL/*M2]FG;8\Q\$0;/%%NV/X6_]!->L54@TRPMI1+!96\4@Z,D8
M!'XU;HE)R=V&#P\J%/DD[ZA1114G8%?/_P <?!36>H+XHLH_]'N2$NPH^Y)V
M;Z-_,>]?0%5M1T^UU73KBPO8EEMKA"DB-W!IIV$U<^)*]>^#WQ'71YD\.:Q-
MBPE?_19G/$+G^$G^Z3^1^M<7X\\$WG@K77M90TEE*2UK<8X=?0_[0[BN5K3=
M$;'W)17S]\-?C VEI#HOB21GLQA(+P\M$.P?U7WZC^7OMO<0W5ND]O*DL,@W
M(Z-E6'J#6;5BT[DE%%87B+Q7IWAR ^>_F7)'R6Z'YC]?0>]$8N3LB:E2%.+E
M-V1?U?5[/1+![R\DVHO11U<^@'K7AWB'Q!=>(=2:ZG.U!Q%$#PB^GU]ZBUSQ
M!?>(+XW-Y)P.(XE^Z@] /ZUEYKTZ-#DU>Y\=F.82Q+Y(:17X^H_-7-,T^XU;
M4(;*U3=+*V!Z =R?854BCDGE2*)&>1R%55&23Z5[5X*\)KX>L?/N%#:A./G/
M7RQ_=']:=:HJ:\SGP."EBJEOLK=FWHVDP:+I4-C;CY8Q\S8Y9NY-7Z**\MN[
MNS[J,5"*C'9!7+>,_%<?A^Q,%NP;4)E_=KU\L?WC_2F^*?&EMHD;VUJ5GOR,
M;1RL?NW^%>0WES/?74ES<RM+-(<LS=3711I7=Y;'AYEFD:2=*D[R[]O^#^13
MD+RR-)(Q9V)+,3DDGO6CX>T*;7]8ALHLA"=TKC^!!U-5H+66ZN(X((VDED8*
MJJ.2:]K\*^'(/#&DGS63[3(-]Q*3P,=L^@KLJUN2.FYXF7826*JZ_"M_\OF;
MMM;16=K%;0($BB4(BCL!4M5+34[*^=DMKF.5E&2JGG'K]/>K=>4?<))*R"BB
MB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
